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1.  Zusammenfassung 
 
Hyaliner Gelenkknorpel ist frei von Nerven, Blut und Lymphgefäßen und besitzt dadurch nur 
eine begrenzte Regenerationsfähigkeit. Die Zufuhr der Nährstoffe erfolgt ausschließlich per 
Diffusion durch die extrazelluläre Matrix (EZM) und/oder die Synovialflüssigkeit. Nicht 
behandelte Knorpeldefekte können daher im Langzeitverlauf zur Arthrose führen, die als 
Endpunkt einen vollständigen Gelenkersatz erfordert. In den letzten Jahrzehnten wurden 
zahlreiche Therapiekonzepte zur Behandlung von chondralen und osteochondralen Defekten 
entwickelt. Allerdings führt keine der bisherigen Behandlungsstrategien zur Bildung von 
belastbarem Regenerationsgewebe, sondern in der Regel nur zu einer vorübergehenden 
Linderung der Beschwerden. 
Die Arbeitsgruppe Experimentelle Rheumatologie des Uniklinikums Jena befasst sich daher 
mit der Untersuchung von innovativen und/oder klinisch bereits etablierten 
Knorpelersatzmaterialien (Bakterielle Nanocellulose, CaReS®, BioSeed®-C) und entwickelte 
zu diesen Zwecken ein bovines in vitro Knorpelstanzenmodell. 
Ziel der vorliegenden Arbeit war es, verschiedene Knorpelersatzmaterialien in vitro und in 
vivo zu untersuchen. In der ersten Phase wurden die oben genannten 
Knorpelersatzmaterialien in vitro kultiviert und anschließend biomechanisch, 
molekularbiologisch und histologisch untersucht. In der zweiten Phase wurde am Standort 
Jena das Knorpelersatzmaterial BioSeed®-C der Firma TTT in vivo untersucht. Die 
entstandenen Gewebsregenerate wurden nach 6 und 12 Monaten biomechanisch, 
molekularbiologisch und histologisch untersucht. Die gewonnenen Erkenntnisse sollen in die 
Entwicklung standardisierter Verfahren für die Prüfung von Tissue engineering (TE) 
Konstrukten für den orthopädisch-unfallchirurgischen Einsatz einfließen. 
Für die in vitro Versuche wurden bovine Knorpelstanzen adulter Rinder mit einem zentralen 
Defekt versehen. Nach Applikation der Füllmaterialien in die Knorpeldefekte wurden die 
Knorpelstanzen unter standardisierten Bedingungen für bis zu 12 Wochen in vitro kultiviert. 
Abschließend wurden die Knorpelstanzen histologisch (n = 4), molekularbiologisch (n = 10) 
und biomechanisch (n = 10) untersucht. Für die in vivo Untersuchung des klinisch etablierten 
Knorpelersatzmaterials BioSeed®-C wurden 2 Knorpeldefekte auf der medialen 
Femurkondyle adulter Merinoschafe generiert. Ein Defekt wurde mit einem allogen 
besiedelten BioSeed®-C Implantat besetzt und ein Defekt diente als Leerdefekt (Kontrolle). 
Nach einer Standzeit von 6 und 12 Monaten erfolgte die biomechanische, 
molekularbiologische und histologische Analyse des Regeneratgewebes. Neben den in vitro 
und in vivo Versuchen wurde auch die Knorpeldickenvorhersage mittels Nahinfrarot- 
Spektroskopie (NIRS-B) ex vivo untersucht. Mit diesem Messsystem ist es möglich, die 







untersuchen und in einem weiteren Schritt die Qualität von Regeneratgewebe in vivo zu 
beurteilen. 
Im Rahmen dieser Arbeit ist es gelungen, mit dem in der Arbeitsgruppe Experimentelle 
Rheumatologie etablierten in vitro Modell innovative und/oder klinisch bereits etablierte 
Knorpelersatzmaterialien (BNC, CaReS®, BioSeed®-C) über einen Zeitraum von bis zu 12 
Wochen zu kultivieren und so die biomechanischen Eigenschaften (push-out Versuche) und 
molekularen Prozesse zu untersuchen, die bei der Knorpelregeneration stattfinden. Dieses 
Modell scheint allerdings nicht für die Untersuchung von resorbierbaren Materialien wie 
BioSeed®-C geeignet zu sein. Weiterhin zeigte die Auswertung der in vivo Proben trotz 
klarer klinischer Erfolge im Humansystem mit BioSeed-C im Schafsmodell noch keine 
eindeutige Ausbildung von vollwertigem Knorpelgewebe. Neben den in vitro und in vivo 
Untersuchungen ist es zudem gelungen, mittels der nicht invasiven Nahinfrarot- 
Spektroskopie (NIRS-B) eine zerstörungsfreie Vorhersage der Knorpeldicke im Knie des 
Großtiermodells Schaf zu realisieren (ex vivo Studie). 
Die vorliegende Arbeit liefert vielversprechende Erkenntnisse, um die Entwicklung 
standardisierter Verfahren für die Prüfung von TE Konstrukten für den orthopädisch- 
unfallchirurgischen  Einsatz  voran  zu  treiben.  Die  Modifizierung  des  etablierten  in  vitro 
Modells für die Untersuchung von resorbierbaren Materialien sowie weiterführende 
Untersuchungen zur Vorhersage von Knorpeldicke und Knorpeleigenschaften mittels der 
nicht invasiven Methode NIRS-B stellen interessante Aufgaben für zukünftige Studien dar. 
3 








2.1. Aufbau und Eigenschaften des hyalinen Knorpels 
 
Der hyaline Knorpel ist makroskopisch durch seine glatte und milchig durchscheinende 
Oberfläche charakterisiert und überzieht als wenige Millimeter dicke Schicht die Oberfläche 
der angrenzenden Knochen der beweglichen Gelenke. Hyaliner Knorpel ist dabei aufgrund 
seiner Zusammensetzung in der Lage, einen reibungsarmen Bewegungsablauf zu 
gewährleisten und kann zudem Belastungskräfte von bis zum 5-fachen des eigenen 
Körpergewichtes aufnehmen. 
Adulter Knorpel ist frei von Nerven, Blut- und Lymphgefäßen, und besitzt daher nur eine 
begrenzte Regenerationsfähigkeit. Die Zufuhr der Nährstoffe erfolgt ausschließlich per 
Diffusion durch die extrazelluläre Matrix (EZM) und/oder die Synovialflüssigkeit. 
Die zellulären Komponenten des adulten Knorpels sind die Chondrozyten, die lediglich 2 - 
 
5% des Gesamtvolumens ausmachen (Stockwell 1979) und in eine EZM eingebettet sind. 
Die  grundlegende  Komponente  der  EZM  ist  neben  Wasser  und  Ionen  (ca.  80%)  ein 
Netzwerk aus strukturellen Makromolekülen (Kollagene, Proteoglykane und verschiedene 
Glykoproteine; ca. 20%). Das komplexe Zusammenwirken dieser Komponenten bestimmt 
dabei die wesentlichen biomechanischen Eigenschaften des hyalinen Knorpels (Mollenhauer 
und Aurich 2003). 
Den Hauptbestandteil des kollagenen Fasergerüstes bildet das Kollagen Typ II mit ca. 90 – 
 
95%, das maßgeblich für die Stabilität des Knorpels bei einwirkenden Zug- und Scherkräften 
verantwortlich ist (Benninghoff 1925). Weitere Bestandteile sind die Kollagene Typ VI, IX, X 
und XI und Proteoglykane (Kuettner 1992). Das größte und am häufigsten vorkommende 
Proteoglykan ist das Aggrekan. Ein Proteoglykanmolkül besteht aus einem zentralen Protein, 
an das negativ geladene sulfatierte Glykosaminoglykan-Ketten (z. B. Chondroitinsulfat, 
Keratansulfat und Dermatansulfat) gebunden sind. Über die Bindung vieler solcher Moleküle 
an eine Hyaluronsäurekette entstehen unterschiedlich große Polymeraggregate, die durch 
ihre polyanionischen Eigenschaften eine hohe Bindungskapazität für Kationen und damit für 
Wasser  besitzen.  Dies  wiederum  beeinflusst  die  spezifischen  und  funktionellen 
Eigenschaften des Knorpels (Putz 2008). 
Morphologisch lässt sich der hyaline Knorpel in vier verschiedene Zonen unterteilen, die sich 
in der äußeren Form der Chondrozyten sowie deren Aktivität und Orientierung zur 
Gelenkfläche  unterscheiden  (Buckwalter  und  Lohmander  1994,  Buckwalter  und  Mankin 
1998, Poole et al. 2001) (Abb. 1). 
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I.     Die  Tangentialzone  ist  mit  10  –  20%  der  Knorpeldicke  die  dünnste  Lage  des 
Gewebes und bildet die Gleitschicht des Knorpels. Die Chondrozyten in dieser Zone 
sind abgeflacht, spindelförmig und parallel zum flachen Kollagenfasergerüst 
angeordnet.  Durch  die  parallele  Anordnung  der  Kollagenfasern  gilt  die 
Tangentialzone als Zone mit der höchsten Druck- und Zugfestigkeit (Bullough und 
Goodfellow 1968, Kempson et al. 1973). 
II.     Die Transitionalzone oder auch Übergangszone macht 40 – 60% der Knorpeldicke 
aus. Die Chondrozyten in dieser Zone besitzen eine unregelmäßige Anordnung in 
einem sich überschneidenden Kollagenfasergerüst. 
III.    Die Radialzone macht 30 – 40% der Knorpeldicke aus. Die Anordnung der 
Chondrozyten und der Kollagenfasern ist dabei senkrecht zur Gelenkoberfläche. Die 
Zelldichte ist geringer als in der Transitionalzone. 
IV.    Die Zone des kalzifizierten Knorpels oder auch Mineralisierungszone bildet den 











Vor allem im Bereich des Kniegelenkes entstehen Knorpeldefekte meist durch Traumata 
oder im Rahmen der primären Arthrose. Knorpeldefekte mit einer Größe von mehr als 2 – 4 
cm2  heilen dabei selten spontan (Convery et al. 1972, Furukawa et al. 1980, Meachim und 
Roberts 1971, Mitchell und Shepard 1987) und können so zu einer sekundäre Arthrose 
führen (Madry et al. 2011, Mankin 1982). Eine entscheidende Rolle spielen dabei unter 
anderem die Avaskularität des Knorpelgewebes und die geringe Zelldichte (Mankin 1982). 
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Weiterhin sind die Chondrozyten in ein Gerüst aus Kollagenfasern und Proteoglykanen 
eingebunden, und können daher nicht sofort zum Ort der Schädigung migrieren (Khan et al. 
2008). Dies stellt insbesondere bei jungen Patienten ein großes Problem dar. 
 
 
Es werden 2 Arten von Knorpelverletzungen unterschieden: rein chondrale Knorpeldefekte 
und osteochondrale Knorpeldefekte, die bis in den subchondralen Knochen reichen (Noyes 
und Stabler 1989, Wirth und Rudert 1996). Chondrale Defekte, die häufig nach einem 
Trauma entstehen, führen dabei nicht zwangsläufig zu einer frühen Arthrose (Buckwalter 
2002). Verschiedene Studien haben allerdings gezeigt, dass nach Knorpelverletzungen in 
den Kniegelenken junger Sportler bis zu 40% der untersuchten Patienten innerhalb von 14 
Jahren Zeichen einer Arthrose entwickeln (Messner und Maletius 1996). Ob es im späteren 
Verlauf dann tatsächlich zur Entwicklung einer Arthrose kommt, hängt von verschiedenen 
Parametern wie Größe, Tiefe und Lokalisation des Defekts, Patientenalter sowie 
Aktivitätsniveau ab (Buckwalter 2002, Lotz und Kraus 2010, Gaissmaier et al. 2003). Bei 
osteochondralen Defekten hingegen kommt es durch die Eröffnung ossärer Blutgefäße zu 
einer lokalen Einblutung in die Defekte. Durch das zusätzliche Einwandern von pluripotenten 
mesenchymalen Stammzellen aus dem Knochenmark kommt es zur Bildung von 
Reparaturgewebe (Shapiro et al. 1993). Dabei scheint es zu einer vollständigen 
Rekonstruktion des knöchernen Anteils mit einer unzureichenden Integration des chondralen 
Anteils zu kommen. Dies kann aufgrund der biomechanischen Belastungen im Gelenk 
wiederum zu degenerativen Veränderungen und somit zur Entstehung einer Arthrose führen 
(Shapiro et al. 1993). 
 
2.3. Behandlungsstrategien zur Behandlung von Knorpeldefekten 
 
Wie bereits erwähnt, besitzt der Gelenkknorpel nur eine begrenzte Regenerationsfähigkeit. 
Nicht behandelte Knorpeldefekte können daher im Langzeitverlauf zur Arthrose führen, die 
als Endpunkt einen vollständigen Gelenkersatz erfordert. Neben konservativen 
Behandlungsmöglichkeiten wie Krankengymnastik ist daher das primäre Ziel von modernen 
Operationsverfahren, die normale Gelenkfunktion mit schmerzloser Beweglichkeit wieder 
herzustellen und den Einsatz einer Totalendoprothese (TEP) so lange wie möglich zu 
verzögern. 
In den letzten Jahrzehnten wurden daher zahlreiche Operationsverfahren entwickelt, um eine 
ausreichende   Knorpelregeneration   zu   stimulieren.   Keine   dieser   bisher   entwickelten 
Methoden stimuliert jedoch die Bildung von hyalinem Gelenkknorpel, sondern induziert 
überwiegend lediglich die Ausbildung von Faserknorpel sowie in der Regel nur eine 
vorübergehende Linderung der Beschwerden. 
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Aktuell werden für die Behandlung von chondralen Knorpeldefekten markraumeröffnende 
Verfahren (Mikrofrakturierung), osteochondrale Transplantate (OATS) sowie die autologe 
Chondrozytentransplantation (ACT) angewendet (Madry et al. 2011). Die Wahl der 
Behandlungsmethode ist dabei von der Art der Knorpelverletzung, dem Patientenalter sowie 
der Defektgröße und -lage abhängig (Madry et al. 2011, Vaquero und Forriol 2012). 
 
2.3.1. Lavage, Débridement und Shaving 
 
Bei kleinen chondralen Knorpeldefekten bieten sich symptomatische Therapieverfahren wie 
Lavage, Débridement oder Shaving an, die kurzfristige Erfolge bei bis zu 80% der Patienten 
und mittelfristige Erfolge bei bis zu 50% der Behandelten aufweisen (Buckwalter und 
Lohmander 1994). Bei der Lavage wird mittels Arthroskopie das Gelenk von den abgelösten 
Knorpelfasern und Entzündungsmediatoren freigespült. Die Methode des Shaving entfernt 
abgelöste Knorpelteile, die mechanische Probleme verursachen können (Baumgaertner et 
al. 1990, Buckwalter und Lohmander 1994). Klinisch und experimentell wurden in 
verschiedenen Studien allerdings Nekrosen sowie Schädigungen im angrenzenden Gewebe 
beobachtet (Kim et al. 1991, Korkala 1988). Die Methode des Débridement wurde 1941 von 
Magnuson erstmals beschrieben. Dabei erfolgt die Entfernung von überschüssigen 
Knorpelfragmenten mit anschließender Glättung der Knorpelränder und der 
Knorpeloberfläche. Magnuson (Magnuson 1974) und Haggart (Haggart 1947) konnten dabei 
eine temporäre Verbesserung des funktionellen Befundes bei bis zu 70% der Patienten 
zeigen. Bei all diesen Verfahren kommt es allerdings nicht zu einer Ausbildung von 




Die Mikrofrakturierung ist die am häufigsten angewendete Methode für die Behandlung von 
chondralen Knorpeldefekten. Sie hat das Ziel, pluripotente Stammzellen aus dem 
Knochenmark in den Defekt zu bringen, um die Bildung von Ersatzknorpel zu stimulieren. 
Neben der als erstes von Pridie 1959 beschriebenen Technik und der Abrasionsarthroplastik 
nach Johnson (Johnson 1986) entwickelte Richard Steadman 1985 ein weiteres Verfahren 
der Mikrofrakturierung (Steadman et al. 1997). Bei dieser Variante der Mikrofrakturierung 
handelt es sich um ein kostengünstiges, einstufiges Verfahren, welches im Rahmen eines 
arthroskopischen Eingriffs durchgeführt werden kann und eine geringe Komplikationsrate 
aufweist (Richter und Diederichs 2009). Der Vorteil gegenüber der Predie-Bohrung ist dabei 
das Fehlen der  Schädigung  des subchondralen Knochens (Matthews und Hirsch 1972) 
durch Hitze und der damit verbundenen Nekrosen. 
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Steadman bringt dabei mehrere Perforationen in den freiliegenden suchondralen Knochen 
ein, aus denen zusätzlich Blut aus dem Mark austreten kann. Die darin enthaltenen 
pluripotenten Stammzellen können durch biologische und biomechanische Faktoren in 
Knorpel und Knochenzellen differenzieren. Das Ergebnis ist ein defektfüllender, stabiler und 
belastbarer Faserknorpel (Buckwalter und Lohmander 1994, Shapiro et al. 1993, Burkart et 
al. 2001). 
Allerdings ist der gebildete Faserknorpel den mechanischen Anforderungen langfristig nicht 
gewachsen und es kommt je nach Defektgröße auch nachfolgend noch zur Ausbildung einer 
Arthrose (Imhoff et al. 1999). Klinisch zeigte sich durch die Behandlung mittels 
Mikrofrakturierung bei bis zu 77% der Patienten nach 2-5 Jahren eine Verbesserung der 




2.3.3. Autologe Chondrozytentransplantation (ACT) 
 
Für   die   Behandlung   von   größeren   Defekten   hat   sich   die   durch   die   schwedische 
Arbeitsgruppe um Peterson und Brittberg 1994 entwickelte autologe 
Chondrozytentransplantation  (ACT)  zum  Goldstandard  entwickelt  (Brittberg  et  al.  1994). 
Dabei  werden  zunächst  die  Chondrozyten  aus  einer  arthroskopisch  gewonnen 
Knorpelbiopsie isoliert, in vitro vermehrt und in einer zweiten OP als Zellsuspension in den 
vorbereiteten Knorpeldefekt injiziert (Brittberg et al. 2003). Ein aus der Tibiaoberfläche 
gewonnener Periostlappen wird als mechanischer Schutz wasserdicht am umliegenden 
Knorpel vernäht. Dieser enthält neben den im Periostlappen enthaltenen Wachstumsfaktoren 
auch mesenchymalen Stammzellen (Peterson et al. 2000, O'Driscoll und Fitzsimmons 2001). 
Die Technik der ACT wurde dabei kontinuierlich weiterentwickelt, so dass anstelle des 
aufwändig gewonnen Periostlappens eine resorbierbare Kollagenmatte eingeführt wurde 
(Haddo et al. 2004, Bentley et al. 2003). Neben der Behandlung von großen Knorpeldefekten 
(3 bis zu 10 cm2, (Behrens et al. 2004, Gomoll et al. 2010, Niemeyer et al. 2010)) wird die 
ACT auch bei kleineren Defekten angewendet, bei denen andere Methoden nicht erfolgreich 
waren (Niemeyer et al. 2010, Madry und Pape 2008). 
In Abhängigkeit von dem Defektort sowie der Art des Defektes wurden in Langzeitstudien 
über einen Zeitraum von bis zu 20 Jahren gute bis sehr gute klinische Ergebnisse festgestellt 
(Minas 1998, Peterson et al. 2010, Peterson et al. 2002, Moseley et al. 2010, Micheli et al. 
2001, Henderson et al. 2005, Erggelet et al. 2000). Dennoch weist die ACT eine Reihe von 
Nachteilen  auf.  Zum  einen  neigen  die  isolierten  Chondrozyten  während  der 
Expansionsphase in Monolayer-Kulturen häufig zu einer Dedifferenzierung (Darling und 
Athanasiou 2005). Zum anderen ist die Gewinnung und Fixierung des Periostlappens sehr 
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aufwändig. Weiterhin sind für die ACT zwei operative Eingriffe mit einer hohen Belastung für 
die Patienten notwendig. 
Um diese Nachteile zu umgehen, wurde die ACT unter Verwendung von verschiedenen 
Biomaterialien zu einem trägergekoppelten Verfahren weiterentwickelt. Bei der sogenannten 
matrixassoziierten Chondrozytentransplantation (MACT) werden isolierte Chondrozyten auf 
verschiedene Matrices ausgesät, in vitro kultiviert und anschließend in den Defekt implantiert 
(Andereya et al. 2006). Klinisch etablierte Trägermaterialien sind dabei beispielsweise 
Kollagengele (z. B. CaReS®, Arthro Kinetics Biotechnology GmbH, Krems; Novocart® 3D, 
Tetec  AG,   Reutlingen),   Hyaluronsäuregele  (z.  B.  Hyalograft  C  ®,  Fidia  Advanced 
Biopolymers, Italien; (Nehrer et al. 2006)) oder resorbierbare Biopolymere (z. B. Bioseed 
C®,   BioTissue   Technologies,   Freiburg; (Kreuz et al. 2009)). Die Vorteile der MACT 
gegenüber der ACT sind dabei vor allem in der Vereinfachung der Methode sowie der 
Verkürzung der Operationszeit zu sehen. Studien zeigten bislang keine eindeutigen 
Unterschiede zwischen ACT und MACT im klinischen und histologischen Outcome  (Bartlett 
et al. 2005, Manfredini et al. 2007, Iwasa et al. 2009). 
 
2.3.4. Transplantation osteochondraler Zylinder 
 
Chondrale bzw. osteochondrale Defekte, insbesondere im Knie, stellen heutzutage ein 
gravierendes therapeutisches Problem dar. Bei der Anwendung der osteochondralen 
Transplantation von autologen Knorpel-Knochen Zylindern (OATS) aus demselben Gelenk 
ist das Ziel die Wiederherstellung der Knorpeloberfläche, um Schmerzfreiheit sowie eine 
normale Gelenkfunktion zu erreichen. Dazu werden osteochondrale Zylinder von einer gering 
belasteten Stelle des Gelenkes press-fit in den Knorpel-Knochen-Defekt eingebracht. Diese 
Methode wurde erstmals 1964 von Wagner beschrieben, um größere Knorpeldefekte im 
Kniegelenk zu therapieren. 
Das Verfahren der OATS wurde durch Hangody (Hangody et al. 1996) und Bobic (Bobic 
 
1996) wieder aufgegriffen, verbessert und zu einem arthroskopischen Vorgehen 
weiterentwickelt. Mit dieser OATS Technik gelingt es, im Gegensatz zu anderen 
Operationstechniken   (Mikrofrakturierung,   Débriment,   ACT,   MACT)   sofort   vollwertigen 
hyalinen Knorpel in den Defekt einzubringen. Weiterhin handelt es sich bei der OATS um ein 
einstufiges Operationsverfahren. Ein Nachteil der autologen Transplantation von 
osteochondralen Zylindern besteht allerdings darin, dass autologes Material nur begrenzt zu 
Verfügung steht und so nur Defekte von höchstens 4 cm2 mit dieser Methode behandelt 
werden können. 
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2.3.5. Tissue Engineering 
 
Nach dem heutigen wissenschaftlichen Stand nimmt der Bedarf für neue Therapie-Ansätze 
zur Behandlung von chondralen und osteochondralen Defekten stetig zu. Die Entwicklung 
neuartiger Therapieverfahren für die Herstellung eines biologischen Implantates fordert einen 
interdisziplinären Ansatz aus Technik, Biochemie, Zellbiologie und Medizin. Tissue 
Engineering (TE) basiert dabei auf der Vermehrung autologer Zellen in vitro unter 
Verwendung von biologischem Gewebe, das anschließend als Transplantat in den Patienten 
eingebracht wird (Richter und Diederichs 2009). Die Technologie des TE ist allerdings sehr 
aufwändig, da die Zellen der Patienten zunächst isoliert und kultiviert werden müssen, bevor 
sie anschließend in den Patienten transplantiert werden können. Dabei müssen vor allem 
potenzielle Infektionen ausgeschlossen werden. Eine weitere Voraussetzung für die 
erfolgreiche klinische Anwendung solcher TE-basierten Implantate ist zudem die Herstellung 
einer funktionsfähigen Knorpelmatrix mit ähnlichen biomechanischen Eigenschaften wie 
hyaliner Knorpel (Weise et al. 2000). 
 
2.4. CaReS ® 
 
CaReS® ist ein autologes, dreidimensionales Hydrogel, das aus Kollagen Typ I besteht. 
Zunächst werden aus den bei einer Biopsie entnommenen Knorpelfragmenten die 
Chondrozyten isoliert und ohne weitere Prozesssierung in das Kollagengel eingebracht. 
Dadurch wird das Risiko der Dedifferenzierung der isolierten Chondrozyten während der 
mehrmaligen Passagierung minimiert. Das Transplantat kann in jeder gewünschten Größe 
hergestellt werden (Andereya et al. 2006).  In vivo Studien haben zudem gezeigt, dass es 
auch bei der Verwendung eines zellfreien Kollagen Typ I Hydrogels zur Ausbildung von 
Reparaturgewebe kommt, das mit dem Gewebe nach der Implantation von zellhaltigen 
Transplantaten vergleichbar ist. Diese Ergebnisse zeigen, dass es bei den zellfreien 
Transplantaten zur Einwanderung von Chondrozyten aus dem umliegenden Gewebe kommt, 
die zur Knorpelregeneration beitragen (Andereya et al. 2006, Maus et al. 2008, Schneider et 
al. 2011a, Welsch et al. 2010). 
 
2.5. Bakterielle Nanocellulose (BNC) 
 
Cellulose ist ein in der Natur häufig vorkommendes Polysaccharid und ein nahezu 
unerschöpflicher polymerer Rohstoff mit großer Bedeutung für industrielle Anwendungen. 
A.J. Brown (Brown 1886b) beschrieb im Jahr 1886 erstmals die Bildung von Cellulose durch 
gram-negative Bakterien der Gattung Gluconacetobacter xylinum und stellte fest, dass die 









war (Brown 1886b, Brown 1886a). Die Synthese der BNC erfolgte an der Übergangszone 
zwischen Luft und Flüssigkeit und die BNC wies ein feinstrukturiertes dreidimensionales 
Netzwerk mit einem Wassergehalt von bis zu 99% und einer ausgeprägten Tunnel- und 
Porenstruktur auf (Abb.2; (Klemm et al. 2011)). 
 
 
Abb. 2: Struktur und Form bakterieller Nanocellulose (BNC). (A) molekulare Cellulosekette; (B) 
rasterelektronenmikroskopische (REM) Aufnahme des gefriergetrockneten BNC-Netzwerks 
(Vergrößerung 10.000); (C) BNC-Vlies aus statischer Kultur (Klemm et al. 2006). 
 
 
Mitte des 20. Jahrhunderts begannen Hestrin und Schramm mit der Erforschung der 
grundlegenden Stoffwechselvorgänge der Celluloseproduktion sowie der Erarbeitung eines 
optimierten Kultivierungsmediums (Hestrin und Schramm 1954, Schramm et al. 1957, 
Schramm und Hestrin 1954b, Schramm und Hestrin 1954a). Dieses nach seinen Erfindern 
benannte Medium wird unter Laborbedingungen bis heute für die Produktion von BNC 
verwendet. Durch Veränderungen des biotechnologischen Prozesses (statisch, dynamisch, 
in situ-Modifizierung, post-Modifizierung) ist es möglich, die strukturelle Charakteristik der 
BNC und ihre Eigenschaften zu verändern (Heßler 2008, Seifert 2004, Haigler et al. 1982, 
Astley et al. 2001, Evans et al. 2005, Nakayama et al. 2004). Durch diese vielseitigen 
Möglichkeiten der Modifikation sowie die charakteristischen Eigenschaften der BNC (hohe 
mechanische Stabilität, Biokompatibilität, hohes Elastizitätsmodul und enorme Reißfestigkeit 
(Kramer 2008)) ist sie ein Biomaterial mit hohem Anwendungspotenzial vor allem im 
medizinischem Bereich (Jonas und Farah 1998, Kramer 2008). 
Klinisch wird die BNC bereits als Wundauflage zur Behandlung von Verbrennungen, Ulzera, 









für die Behandlung von paradontalen Erkrankungen (Gengiflex ®) oder für die 
Rekonstruktion von Dura-Defekten (SYNTHECEL®, (Rosen et al. 2011)) verwendet. 
Weiterhin  scheint die bakterielle Nanocellulose aufgrund ihrer  biomechanischen 
Eigenschaften und ihrer Biokompatibilität ein innovatives Implantatmaterial zur Behandlung 
von Meniskus- (Bodin et al. 2007, Martinez et al. 2012) und Knorpelschäden (Muller et al. 
2006, Gama et al. 2012, Ahrem et al. 2014, Andersson et al. 2010, Lopes et al. 2011, 
Svensson et al. 2005) zu sein. 
 
2.6. BioSeed-C ® 
 
BioSeed®-C ist ein klinisch etabliertes Chondrozyten-Transplantat, das aus einem 
resorbierbaren Vlies aus Polyglykolsäure (PGA) besteht und mittels chirurgischer Nähte oder 
Fibrinkleber im Defekt fixiert wird. BioSeed®-C wird für die Behandlung von humanen 
Gelenkknorpeldefekten im Knie, im Fußgelenk oder der Hüfte erfolgreich eingesetzt und 
bedient sich der Methode der autologen Chondrozytentransplantation (ACT). Das 
resorbierbare PGA-Vlies wird dabei vor seiner Implantation in den Knorpeldefekt mit zuvor 
entnommenen  und  expandierten  Chondrozyten  besiedelt  und  anschließend  transossär 
fixiert. Die PGA Transplantate besitzen eine textile und zugfeste Struktur mit 
Einzelfaserdurchmessern von 17 µm (Endres et al. 2012). Innerhalb von 7 Tagen verlieren 
sie bereits 50% ihrer mechanischen Festigkeit und nach 42 Tagen sind die Transplantate in 
vitro komplett resorbiert (Dunzel et al. 2013, Endres et al. 2007). In vivo ist BioSeed®-C nach 
einem Zeitraum von etwa 5 Wochen resorbiert (Pillai und Sharma 2010). 
In verschiedenen in vitro und in vivo Studien wurde gezeigt, dass es durch die Behandlung 
des Knorpeldefektes mit einem autologen BioSeed®-C Transplantat zur Bildung von 
knorpelspezifischer ECM im Transplantat kommt (Hunter und Levenston 2004, Kaps et al. 








3.  Ziele der Arbeit 
 
Zellfreie bzw. zellhaltige TE Konstrukte für die Behandlung von chondralen und 
osteochondralen Defekten unterliegen derzeit unterschiedlichen Zulassungsbedingungen 
(Guidlines der EMA zu „Human Cell-based Medicinal Products“). In dieser Richtlinie wird 
unter anderem auch die standardisierte mechanische Testung der Konstrukte betont. Aus 
diesem Grund beschäftigte sich das BMBF Verbundprojekt „QuReGe“ mit der Entwicklung 
bzw. der Etablierung von validen Prüfverfahren von TE Konstrukten für den orthopädisch- 
unfallchirurgischen Einsatz. 
Ziel der vorliegenden Arbeit war es, verschiedene z. T. etablierte klinische 
Knorpelersatzmaterialien in vitro und in vivo zu untersuchen. Die Arbeitsgruppe 
Experimentelle Rheumatologie des Universitätsklinikums Jena verfügt über ein etabliertes in 
vitro Modell (bovines Knorpelstanzenmodell), das für die Testung genutzt wurde. Untersucht 
wurden die bereits klinisch zugelassenen Knorpelersatzmaterialien BioSeed®-C (zellfrei und 
zellhaltig) und das Kollagen Typ I Hydrolgel CaReS® (zellfrei und zellhaltig) sowie 
unmodifizierte BNC. 
In der ersten Phase wurden die oben genannten Knorpelersatzmaterialien über einen 
Zeitraum von bis zu 12 Wochen in vitro kultiviert und anschließend biomechanisch, 
molekularbiologisch und histologisch untersucht. In der zweiten Phase wurde am Standort 
Jena das Knorpelersatzmaterial BioSeed®-C der Firma TTT in vivo untersucht. Die 
entstandenen Gewebsregenerate wurden nach 6 und 12 Monaten biomechanisch, 
molekularbiologisch und histologisch untersucht. 
Die gewonnenen Erkenntnisse sollen in die Entwicklung standardisierter Verfahren für die 
 
Prüfung von TE Konstrukten für den orthopädisch-unfallchirurgischen Einsatz einfließen. 
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Limitations of matrix-assisted autologous chondrocyte implantation to regenerate functional 
hyaline cartilage demand a better understanding of the underlying cellular/molecular processes. 
Thus, the regenerative capacity of a clinically approved hydrogel collagen type I implant was 
tested in a standardized bovine cartilage punch model. 
Methods 
 
Cartilage rings (outer diameter 6 mm; inner defect diameter 2 mm) were prepared from the 
bovine trochlear groove. Collagen implants (± bovine chondrocytes) were placed inside the 
cartilage rings and cultured up to 12 weeks. Cartilage-implant constructs were analyzed by 
histology (hematoxylin/eosin; safranin O), immunohistology (aggrecan, collagens 1 and 2), as 
well as for protein content, mRNA expression, and implant push-out force. 
Results 
 
Cartilage-implant constructs revealed vital morphology, preserved matrix integrity throughout 
culture, progressive, but slight proteoglycan loss from the “host” cartilage or its surface and 
decreasing proteoglycan release into the culture supernatant. In contrast, collagen 2 and 1 
content of cartilage and cartilage-implant interface was approximately constant over time. Cell- 
free and cell-loaded implants showed: (1) cell migration onto/into the implant; 
(2)   progressive   deposition   of   aggrecan   and   constant   levels   of   collagens   1   and   2; 
(3) progressively increased mRNA levels for aggrecan and collagen 2; and (4) significantly 
augmented push-out forces over time. Cell-loaded implants displayed a significantly earlier and 
more long-lasting deposition of aggrecan, as well as tendentially higher push-out forces. 
Conclusion 
Preserved tissue integrity and progressively increasing cartilage differentiation and push-out 
forces for up to 12 weeks of cultivation suggest initial cartilage regeneration and lateral bonding 






bovine cartilage punch model, collagen type I hydrogel, matrix-associated cartilage 
transplantation (MACT), (immuno)histology, implant push-out force 
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Partial- and full-thickness traumatic or degenerative cartilage lesions of the knee are common 
and lead to progressive deterioration of the cartilage and finally osteoarthritis. Efficient and 
reliable methods for successful cartilage repair, including autologous chondrocyte implantation 
(ACI), microfracture, and osteoarticular transfer/mosaicplasty, are thus highly sought and have 
shown some promise in initial cartilage regeneration (Hunziker 2002, Musumeci et al. 2014). 
These methods, however, mostly do not stop the progression of cartilage degeneration and 
usually result in an  unpredictable outcome concerning: (1) defect coverage; (2) fibrous or 
hyaline features of the repair tissue; and (3) considerably weaker mechanical properties and 
higher permeability of the repair tissue compared with native cartilage (Dell'Accio et al. 2006, Ye 
et al. 2014). 
Novel tissue engineering techniques, for example, second-generation ACI techniques such as 
matrix-assisted chondrocyte implantation (MACI), have led to an improvement of traditional 
methods and have recently entered clinical practice, usually aiming at providing stable and long- 
lasting attachment of the regenerated cartilage to the defect area (Bachmann et al. 2004, 
Dewan et al. 2014, Gobbi et al. 2015, Kon et al. 2009). 
These techniques show the advantage of a decreased operation time, limited surgical trauma, 
and lack of complications associated with the use of periosteum in first-generation ACI (e.g., 
graft overgrowth) and have employed materials such as collagen membranes (type I/III collagen 
membrane) (Bartlett W. 2006, Gillogly und Wheeler 2015, Steinwachs und Kreuz 2007). 
One commercial MACI product (type I collagen-based CaReS) has been extensively applied in 
Europe (and “off-label” in the United States) and is currently used with some clinical success 
(Schneider  et  al.  2011b).  CaReS,  a  3-dimensional  hydrogel,  is first  seeded  with  in  vitro– 
enriched  autologous  chondrocytes  and  then  introduced  into  the  debrided  cartilage  defect. 
Studies in the large animal model Goettinger minipig have recently shown that even a cell-free 
collagen type I hydrogel yields high-quality cartilage repair tissue comparable to that obtained 
after implantation of the cell-seeded implant. This suggests that cells migrating into the defect 
site from the surrounding cartilage may participate in the regeneration of cartilage (Andereya et 
al. 2006, Maus et al. 2008, Schneider et al. 2011a, Welsch et al. 2010). However, to our 
knowledge, there are presently no in vitro studies addressing the cellular and molecular 
mechanisms of cartilage regeneration in cartilage-implant constructs containing this cell-based 
collagen implant. 
The main aim of the study was thus to analyze the behavior of this collagen implant in an in vitro 
model and to assess whether the results reflect its clinical performance for the therapy of 
cartilage defects. The following hypotheses were tested: (1) the experimental in vitro model is 
suitable for pre-testing of implants intended for the clinical regeneration of cartilage defects; (2) 
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the model allows the description of the cellular and molecular processes underlying cartilage 
regeneration in vitro; (3) the cell-free and/or cell-loaded collagen implant supports the 
regeneration of the cartilage defect (via cell migration and tissue formation) in the in vitro model 
by its physicochemical and molecular structure. 
 
For  this purpose,  a novel cartilage implant model was developed consisting of: (1) “host” 
cartilage cylinders resected from bovine femoral condyles using standardized punches; and (2) 
inserted matrix implants. The cylinders were filled with the cell-free or cell-loaded collagen I 
scaffold,    cultured    for    periods    of    up    to    12    weeks,    and    then    subjected    to: 
(1) (immuno)histological staining (hematoxylin/eosin, safranin O; aggrecan, collagens 1 and 2); 
(2)  protein  assays  (dimethyleneblue-binding  [DMB]-test  for  tissue  proteoglycan  analysis; 
enzyme-linked   immunosorbent   assay   [ELISA]   for   aggrecan,   collagens   1   and   2); 
(3)  transcriptional  analysis  (expression  of  aggrecan,  collagen  1,  and  collagen  2);  and 





Preparation/Culture of Cartilage Rings with Cell-Free or Cell-loaded Collagen Implants 
 
 
Bovine cartilage was obtained from the knee joint of German Holstein Friesian Cattle (age 24 
months) (Pretzel et al. 2013). Collagen implants (Amedrix GmbH, Esslingen; Germany; cell-free 
or cell-seeded with bovine chondrocytes; ± cells; cell isolation and seeding according to internal 
guidelines of the producer) were placed into the inner defect of the cartilage rings (Fig. 3). The 
constructs were  then  embedded  in  an  agarose  cylinder  in  48-well  plates  (Fig.  3A-E)  and 
cultured for 0, 4, 8, 10, and 12 weeks at 37°C and 5% CO2 in Dulbecco’s modified Eagle’s 
culture medium (DMEM; containing 5% fetal calf serum [FCS], 1% gentamycin, and 0.1% ITS 
(insulin-transferrin-selenium)–culture supplement [final concentrations: 5 µg/ml insulin and 
transferrin, 5 ng/ml selenic acid; BD Biosciences, Heidelberg, Germany]). Media were changed 
3 times a week. 
 
In each experimental series, 120 technical replicates of cartilage rings each were obtained from 
one animal each for both cell-free and cell-loaded collagen implants (n = 5 and 6 experimental 
series, respectively) and subsequently analyzed histologically (n = 4), biochemically (n = 10; n = 
5 each for real time polymerase chain reaction [RT-PCR] and protein extraction), and 
biomechanically (n = 10; total of 24 samples for each of the 5 time points; see below). 
Supernatants were pooled over 1 week and stored at −20°C for further ELISA analysis. 
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Figure 3: Scheme of the in vitro model. For embedding of the cartilage-implant constructs, hot liquid 
agarose (2%) was added into the wells of a 48-well plate (A). Cylindrical pockets of a defined size (6 mm) 
were created by inserting a metal-pin plate into the hot agarose until it gelated (B, C). The central defects 
of the cartilage rings (diameter 2 mm) were filled with the collagen implant (cell-free/cell-loaded; diameter 
6 mm) using forceps (C1) and, after embedding the resulting constructs into the agarose (D), culture 
medium was added (E). After in vitro culture, cartilage-implant constructs were subjected to histological 
characterization. Also, gene expression of chondrocytes isolated from the “host” cartilage, cells on the 
cartilage surface, and the collagen implant was analyzed (F). At the protein level, the amount of cartilage 
components released into the supernatant, as well as the remaining content in “host” cartilage rings and 






Cartilage rings were obtained at weekly intervals from in vitro culture, minced using a scalpel 
and a pair of scissors and initially digested with pronase E (Merck, Darmstadt, Germany; 1 
mg/ml) in serum-free DMEM for 1 hour at 37°C, 5% CO2, and 95% humidity under constant 
stirring. After three washes in phosphate-buffered saline (PBS: 137 mM NaCl, 2.7 mM KCl, 10 
mM Na2HPO4× 2 H2O, 2 mM KH2PO4; pH 7.4), they were incubated for 17 hours at 37°C in 
DMEM containing 5% FCS (Invitrogen, Darmstadt, Germany) and collagenase P (0.1 mg/ml; 
Roche, Mannheim, Germany). Chondrocytes were then centrifuged (1500 rpm; Eppendorf mini 
spin; Eppendorf, Hamburg, Germany) for 10 minutes, washed 3 times with PBS containing 5% 
FCS, and counted. A total of 1 × 104 cells were seeded in culture slides (Becton Dickinson– 
Discovery  Labware  Products,  Bedford,  MA,  USA)  and  cultivated  for  1  day.  Viability  was 
assessed using fluorescein diacetate/propidium iodide life/dead staining (Kunisch et al. 2017). 
Three images  each  were taken in 3 chambers of  the culture slides using  a fluorescence 
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microscope Axiovert200M, an AxioCam MRm camera, and the AxioVision Rel4.8 program (all 
Zeiss, Oberkochen, Germany). Viable and dead cells were counted in all images using the 
cellprofiler soft-ware (www.cellprofiler.org (Carpenter et al. 2006)) and viability was expressed 
as the mean percentage of viable cells. 
 
Histology and immunohistology 
 
 
Paraffin sections of the cartilage-implant constructs were cut into 6 µm sections and stained 
with hematoxylin and eosin (H&E) and safranin O (to assess the proteoglycan content). For 
aggrecan immunhistology, sections were treated with chondroitinase ABC (0.25 U/ml; Sigma- 
Aldrich; 37°C, 90 minutes), blocked with hydrogen peroxide and 10% goat serum/Tris-buffered 
saline (TBS), and incubated overnight at 4°C with the primary antibody (0.1 µg/ml; clone: 
MA85A95; GenTex, Irvine, CA, USA). For collagen 1 and 2 staining, the epitopes were first 
demasked  by  incubation  with  proteinase  K  (code  S3004;  diluted  1:50;  Dako,  Hamburg, 
Germany) for 15 minutes at room temperature (RT). The sections were then subjected to 
blocking of the endogenous peroxidase activity with 0.5% hydrogen peroxide in methanol for 10 
minutes, blocking with 25% normal bovine serum albumin (BSA)/TBS for 30 minutes (both at 
RT), and overnight incubation at 4°C with a primary antibody to bovine collagen 1 (2 µl/ml; 
polyclonal rabbit IgG; Acris, Herford, Germany) or collagen 2 (10 µg/ml; polyclonal rabbit IgG; 
Acris, Herford, Germany).This was followed by incubation for 1 hour at RT with a secondary 
antibody (anti-mouse or anti-rabbit) coupled to horseradish peroxidase (HRP; for collagen 1 and 
2 antibodies) or alkaline phosphatase (ALP; for aggrecan) and visualization of the HRP with 
diaminobenzidine (DAB) and the ALP with Fast Red (both Sigma Aldrich). Sections were then 
counterstained with hematoxylin and mounted with Aquatex (Merck, Darmstadt, Germany) for 
light microscopy. 
(Isotype-matched) control immunoglobulins consistently yielded negative results. 
 
 
Score for Cell Migration 
 
 
Cell migration onto/into the collagen implants was evaluated by 3 independent observers using 
a scoring system, which consisted of 4 levels (0 = implant without cells, 1 = single adherent 
cells, 2 = several adherent cells, 3 = cell layer on the implant) (Pretzel et al. 2013). Data were 
expressed as the means ± standard error of the mean of the values of the three individual 
observers. 
 
Histology/immunohistology Scores for Safranin O, Collagen 1, Collagen 2, and Aggrecan 
 
 
The intensity of the red color in the safranin O staining or the positive signal in the 
immunostaining for aggrecan, collagen 2, and collagen 1 were semiquantitatively evaluated 
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using a scoring system with 4 levels (0 = no staining; 1 = weak staining; 2 = moderate staining; 
 
3 = strong staining) (Pretzel et al. 2013). Scoring was performed by 3 independent observers, 
data were expressed as the means ± standard error of the mean of the values of the 3 individual 
observers. 
 
Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) 
 
 
For the isolation of RNA from: (1) cells located in the matrix of the “host” cartilage; (2) cells 
located on the cartilage surface (see below); and (3) cells migrated onto and into the collagen 
implants (± cells; Fig. 3F), fine pointed forceps were used to first remove the cartilage-implant 
constructs from the agarose wells and then carefully separate the collagen implants (± cells) 
from the surrounding cartilage ring. A total of ten collagen implants were pooled and stored in a 
tube with 300 µL lysis buffer at −80°C for subsequent RNA isolation. The empty cartilage rings 
were then treated for 1 minute in a tube with 300 µl lysis buffer under continuous shaking to 
obtain the RNA from the cells located on the surface of the cartilage rings (Pretzel et al. 2013, 
Pretzel et al. 2009). 
Subsequently, the rings were removed from the buffer and both components were separately 
stored at −80°C. 
The cartilage rings were disintegrated with a pair of scissors in 800 µl TriZol (Life Technologies, 
Carlsbad, CA, USA), incubation at RT for 15 minutes, and centrifugation at 12,000 rpm for 3 
minutes (Ruettger et al. 2010). Total RNA from these samples, the lysed cell fractions (cells on 
cartilage surface) or the collagen implants was then isolated using the Quiagen Kit (RNeasy 
mini kit; Qiagen, Hilden, Germany; including a DNase digestion). 
The RNA eluate (12 µl each) was primed with oligo(d)T for 10 minutes at 72°C and reverse 
transcribed  for  one  hour  at  42°C  using  superscript  II  (Invitrogen).  To  quantify  aggrecan, 
collagens 1 and 2, and the housekeeping gene aldolase, qRT-PCR (i-cycler PCR system; 
BioRad,  Munich,  Germany)  was  performed  using  the  primers  listed  in  Table  1  and  PCR 
products from bovine chondrocytes as standards. Gene expression in all samples was 
normalized to the relative expression level of aldolase. Product specificity was confirmed by 
melting curve analysis and initial cycle sequencing of the PCR products. 





Table 1: Primers, product length, and specific amplification conditions for RT-PCR. 
 
 






Aggrecan CAGAGTTCAGTGGGACAGCA AGACACCCAGCTCTCCTGAA 193 60 84 
Collagen 2 CATCTGGTTTGGAGAAACCATC GCCCAGTTCAGGTCTCTTAG 600 61 83 
Collagen 1 AGCCAGCAGATCGAGAACAT ACACAGGTCTCACCGGTTTC 185 60 86 
Aldolase CACCGGATTGTGGCTCCGGG CGCCCCCGATGCAGGGATTC 170 58 88 
General amplification protocol (40 cycles): initial denaturation for 90 seconds at 95°C; denaturation for 20 
seconds at 94°C, specific primer annealing temperature (see above) for 20 seconds, amplification at 72°C 
for 30 seconds, additional heating step at 84°C; denaturation for one minute at 95°C; cooling to 60°C 






To determine the relative protein amounts of aggrecan, collagen 2, and collagen 1, protein was 
extracted  from:  (1)  the  “host”  cartilage  (after  removal  of  the  collagen  implants);  and 
(2) the cells located on the cartilage surface (see above). Protein from the “host” cartilage was 
isolated by disintegration in 1000 µl of 4 M GuHCL with a pair of scissors and incubation for 48 
hours at 4°C under rotation. Protein from the cells located on the cartilage surface was isolated 
using the acetone precipitate of the lysis buffer according to the supplier’s instruction of the 
RNeasy mini kit (Qiagen). 
 
Quantification of glycosaminoglycans 
 
 
Glycosaminoglycans released from the cartilage-implant constructs into the supernatant during 
culture, as well as the remaining content in the cartilage rings and the cells located on the 
cartilage surface, were quantified using the DMB assay (Chandrasekhar et al. 1987, Farndale et 
al. 1986). Supernatants were analyzed by pooling the supernatants of the respective week and 
group. Briefly, 25 µL of pooled supernatant or extracted/precipitated proteins, respectively, were 
applied to microtiter plates with or without dilution in 0.05 M sodium acetate buffer (pH 6.8). 
After addition of 200 µL DMB reagent (containing 1.9-dimethyleneblue (21 µg/ml), 55 nM formic 
acid; pH 6.8]), absorption was read at 525 nm. A dilution series of a chondroitin-4 sulfate 
standard (Sigma-Aldrich) was used for the generation of a standard curve and the calculation of 
the results. 
 
Enzyme-Linked Immunosorbent Assay (ELISA) 
 
 
Aggrecan, collagen 2, and collagen 1 concentrations in the supernatant during culture, as well 
as the remaining content in the cartilage rings and the cells located on the cartilage surface, 





were quantified using ELISA kits. Supernatants of the cartilage-implant constructs (± cells) after 
 
0, 4, 8, 10, and 12 weeks of cultivation were analyzed by pooling the supernatants of the 
respective week and group. Aggrecan, collagen 2, and collagen 1 concentrations were then 
measured  according  to  the  protocols  of  commercially  available  ELISA  kits  (Chondrex, 
Redmond, WA, USA; BlueGene, Shanghai, China). Absorption at 490 nm was measured using 





Biomechanical testing (n = 10 for each time point) was performed using a static universal test 
system (Zwicki 1120, Zwicki/Roelli, Ulm, Germany). The maximal force required to push out the 
implant from the cartilage rings (Fmax(insert)) was determined using a cylindrical indenter (diameter 
1.8 mm; i.e., 0.2 mm less than the diameter of the central defect). To address remaining friction 
 
forces between indenter and empty “host” cartilage ring, a second identical test was then 
performed and the resulting force Fmax(empty)) was subtracted from the initial push-out force 
[Fmax(insert) − Fmax(empty) = ∆Fmax(res)] and used for further analysis. Values were given in Newtons 
and, in order to allow a comparison with published studies, in kPa after dividing the values in 





Results were expressed as means ± standard error of the mean. Statistical analysis was 




Cell-Free Collagen implants 
 
Morphological Characteristics, Viability, and Cell Migration 
 
 
In the case of cell-free cartilage-implant constructs, lateral contact of the collagen insert to the 
cylindrical defect was maintained throughout tissue culture for 12 weeks (Fig. 4). Despite 
relatively long in vitro culture periods (up to 12 weeks), resident cartilage cells showed vital 
morphology without signs of alterations and positive nuclear staining, thus pointing to suitable 
culture conditions (Fig. 4). The matrix integrity of the cartilage seemed to be largely unaffected 
during the whole culture period (Fig. 4), although cartilage zones located close to the edge of 
the defect were characterized by the appearance of proliferation-induced cell clusters as a 
possible reaction to the initial mechanical tissue disruption (starting at 4 weeks; Fig. 4; see 
hash). In addition, late time points showed empty chondrocyte lacunae as a possible sign of 
chondrocyte emigration from the “host” cartilage ring (Fig. 4; see arrow). 








Figure 4: Hematoxylin & eosin staining of the cartilage-implant constructs (cell-free or cell-loaded 
implants) after placement into the inner defect of the cartilage rings and subsequent culture for 0, 
4, 8, 10, or 12 weeks. Morphological characteristics of the cells in cartilage, implant and at the cartilage- 
implant interface; # proliferation-induced cell clusters; → empty chondrocyte lacunae; * cellular multilayer. 
 
 
The high viability of the chondrocytes in the cartilage rings was confirmed by fluorescein 
diacetate/propidium iodide live-dead staining of chondrocytes enzymatically isolated from the 
cartilage at weekly intervals, resulting in viability rates of > 94% throughout the entire culture 
period (Fig. 5). 
 






Figure 5: Viability of the chondrocytes in the cartilage ring throughout culture. Chondrocytes were 
enzymatically isolated from the cartilage at weekly intervals and cultivated for 1 day. Viability was 
assessed using fluorescein diacetate/propidium iodide staining. Data are expressed as means ± standard 
error of the mean (SEM); the dashed line indicates a viability of 95%. 
 
 
Cartilage-implant  constructs  showed  progressive  formation  of  a  cellular  multilayer  on  the 
surface of the cartilage rings throughout cultivation (Fig. 4; see asterisks), as well as initial 
migration of chondrocytes onto and into the initially cell-free collagen type 1 implants starting at 
4  weeks  of  in  vitro  culture  (Figs.  4  and  6).  There  was  a  significant  increase  of  the  cell 
 
colonization from 0 weeks to all other time points and from 4 weeks to 8 and 12 weeks (Fig. 6). 
 
 



























Figure 6: Semiquantitative scoring of cell migration onto/into the collagen implants after culture 
for 0, 4, 8, 10, or 12 weeks (cell-free; cell-loaded). Degree of migration: 0 = implant without cells, 1 = 
single adherent cells, 2 = several adherent cells, 3 = cell layer on implant; values are shown as means ± 




Both the cells on/in the collagen implants and on the cartilage surface showed mixed fibroblastic 
and chondrocytic features (Fig.  4;  see asterisk for  cell-loaded implants at  12 weeks)  and 





positively stained for safranin O, aggrecan, and collagen 2, but only very weakly or negative for 
collagen 1 (Fig. 7). 
 
 
Content of Proteoglycans, Aggrecan, Collagen 2, and Collagen 1 
 
 
The  finding  of  a  preserved  matrix  integrity  in  the  surrounding  cartilage  ring  was  further 
supported by a very limited, nonsignificant decrease of the safranin O staining intensity over 
time (from a semiquantitative score of 2.8 for the freshly isolated cartilage to a score of 1.9 at 12 





Figure 7: (Immuno)staining of the collagen implants (cell-free) after placement into the inner 
defect of the cartilage rings and subsequent culture for 0, 4, 8, 10, or 12 weeks. Safranin O staining 
and immunostaining for aggrecan, collagen 2, and collagen 1 (for quantification see Fig. 8); staining with 








At the cartilage-implant interface there was also a loss of safranin O staining (from 2.6 to 1.3), 
which reached statistical significance for the 10- and 12-week values in comparison with the 0- 
week and/or 4-week values (Figs. 7 and 8A). In the implant, staining was first noticed at 8 
weeks and then reached a plateau at 10 and 12 weeks (Figs. 7 and 8A), indicating proteoglycan 






Figure 8: Semiquantitative analysis of “host” cartilage, interface, and collagen implants (cell-free). 
Score: 0 = no staining, 1 = weak staining, 2 = moderate staining, 3 = strong staining; values are shown as 
means ± standard error of the mean (SEM); symbols indicate p ≤ 0.05 versus * 0 weeks, # 4 weeks. 
 
 
As for the safranin O staining, a largely constant immunostaining for aggrecan was observed in 
the surrounding cartilage ring and at its interface with the implant throughout the 12-week 
culture  period  (constant  scores  between  1.2  and  1.7  over  time;  Figs.  7  and  8B),  again 
suggesting a minimal loss of proteoglycan during in vitro culture. 
Also, staining for aggrecan in the implant was first noticed at 8 weeks and then reached a 
plateau at 10 weeks (p≤0.05 vs. 0 and 4 weeks) and 12 weeks (Figs. 7 and 8B), confirming 
proteoglycan deposition into the implant. 
As in the case of aggrecan, largely constant immunostaining for collagen 2 was observed 
throughout the 12-week culture period in surrounding cartilage ring (scores between 1.5 and 
1.9), cartilage-implant interface (scores between 2.2 and 2.5), and implant (scores between 0.5 





and 1.4), without any significant differences among the different time points (Figs. 7 and 8C), 
again supporting the concept of a preserved matrix integrity. 
Very little immunostaining for collagen 1 (except for the implant 0-week value, scores mostly 
between 0.2 and 0.7) was observed in surrounding cartilage ring, interface, and implant, without 
any significant differences among the different time points (Figs. 7 and 8D). 
 
DMB Assay (Proteoglycan Content; Tissue Extracts and Culture Supernatant) 
 
 
As observed by safranin O staining and aggrecan immunostaining, there was a limited, 
nonsignificant decrease of the glycosaminoglycan (GAG) content in the surrounding cartilage 
ring over time (from 4911 µg/ml for the freshly isolated cartilage to 3627 µg/ml at 12 weeks, with 
an intermediate peak of 5785 µg/ml at 4 weeks; Supplementary Figure 1A, available in the 
online version of the article). 
The chondrocytes that migrated onto the surface of the cartilage ring generally showed an 
approximately 10-fold lower GAG content, with a significant decrease over time (from 537 µg/ml 
for freshly isolated cartilage to 378 µg/ml at 12 weeks, with an intermediate peak of 689 µg/ml at 
8 weeks; p ≤ 0.05 vs. 4 and 8 weeks for the 10-week time point, p ≤ 0.05 vs. 4 weeks for the 12- 
week time point; Supplementary Figure 1A). 
Also, in the culture supernatant, there was a limited, nonsignificant decrease of the GAG 
 
content over time (from 193 µg/ml at 4 weeks to 146 µg/ml at 12 weeks; Supplementary Figure 
 
1A). This was confirmed by a limited, nonsignificant decrease of the aggrecan release into the 
supernatant over time (ELISA; from 17 ng/ml at 4 weeks to 10 ng/ml at 12 weeks; data not 
shown). 
 
ELISA (Collagens 2 and 1; Tissue Extracts and Culture Supernatant) 
 
 
A significant decrease of the collagen 2 content was observed in the surrounding cartilage ring 
over time (from 1091 ng/ml at 0 weeks to 296 ng/ml at 12 weeks, p ≤ 0.05 vs. 0 weeks for the 8- 
week time point; Supplementary Figure 1C). The chondrocytes migrated onto the surface of the 
cartilage ring showed an approximately 4-fold higher collagen 2 content, with a nonsignificant 
decrease over time (from 3757 ng/ml at 0 weeks to 2644 ng/ml at 12 weeks; Supplementary 
Figure 1C). 
There was also a limited, nonsignificant decrease of the collagen 2 release into the supernatant 
over time (from 1381 ng/ml at 4 weeks to 269 ng/ml at 12 weeks; Supplementary Figure 1C). 
In contrast to the collagen 2 release, there was a limited, but significant increase of the collagen 
 
1 release into the supernatant over time (from 185 ng/ml at 4 weeks to a peak of 422 ng/ml at 8 
weeks and a subsequent plateau; p ≤ 0.05 vs. 4 weeks for the 8-week time point; data not 
shown). 





Gene Expression for Aggrecan, Collagen 2, and Collagen 1 (RT-PCR) 
 
 
Aggrecan expression showed a slight increase over time in cartilage ring (maximum 4-fold 
increase at 12 weeks), cartilage surface cells (maximum 7-fold; 12 weeks), and, interestingly, in 
the implant (maximum 3-fold; 10 weeks; Fig. 9A). 
Whereas the collagen 2 expression in the cartilage ring was constant or even significantly 
decreased (p ≤ 0.05 for 4, 10, and 12 weeks vs. 0 weeks), collagen 2 expression in surface cells 
and implant rose from baseline values to a transient peak at 8 weeks of 13-fold and 9-fold, 
respectively, and thereafter decreased again (Fig. 9B). 
 
Figure 9: Real-time polymerase chain reaction analysis for aggrecan, collagen 1, and collagen 2 
(cell-free implants). mRNA expression for aggrecan (A), collagen 2 (B), collagen 1 (C), 
aggrecan/collagen 1 ratio (D), and collagen 2/collagen 1 ratio (E) was determined prior to and after 4, 8, 
10, and 12 weeks of in vitro culture; relative gene expression of the cells located in the “host” cartilage 
matrix (cartilage), on the cartilage surface (cartilage surface), and on/in the collagen implant (implant); 
values are expressed as means ± standard error of the mean (SEM); symbols indicate p ≤ 0.05 *versus 0 
weeks; #versus 4 weeks; x versus 8 weeks; +versus 10 weeks. 





Whereas collagen 1 expression in cartilage ring and surface cells rose to a transient peak at 8 
weeks of 61-fold and 30-fold, respectively, and thereafter decreased again (surface cells p ≤ 
0.05 for 12 vs. 4 weeks), collagen 1 expression in the implant was constant or even decreased 
over time (Fig. 9C). 
The above changes were reflected in a constant aggrecan/collagen 1 ratio in the cartilage ring, 
and a transient peak at 10 weeks for surface cells (37-fold) and implant (13-fold; Fig. 9D). As for 
the aggrecan/collagen 1 ratio, there was a marginally decreased collagen 2/collagen 1 ratio in 
the cartilage ring (p ≤ 0.05 for 8, 10, and 12 weeks vs. 4 weeks), and a transient peak at 8 or 10 
weeks for surface cells (7-fold) and implant (13-fold; Fig. 9E). 
 
Cell-loaded Collagen implants 
 
 
Morphological Characteristics and Cell Migration 
 
 
The findings in cell-loaded cartilage-implant constructs were generally comparable to those in 
cell-free cartilage-implant constructs, with lateral contact of the implant to the cylindrical defect, 
vital morphology of the resident cartilage for up to 12 weeks cells, and largely preserved matrix 
integrity (Fig. 4). 
As in the case of cell-free constructs, cell-loaded cartilage-implant constructs also showed 
progressive formation of a cellular multilayer on the surface of the cartilage rings throughout 
cultivation (in part with chondrocytic features; Fig. 4; see asterisk at 12 weeks). However, a 
substantial presence/migration of chondrocytes onto and into the initially cell-free collagen type 
1 implants occurred already after 4 weeks of in vitro culture (Figs. 4 and 6). There was again a 
significant increase of the cell colonization from 0 weeks to all other time points (Fig. 6). 
Interestingly, cell-loaded collagen implants showed a significantly faster cell colonization than 
initially cell-free collagen implants (p ≤ 0.05 at 4 weeks; Fig. 6). 
 
Content of Proteoglycans, Aggrecan, Collagen 2, and Collagen 1 
 
 
Also, in this group, there was a very limited, nonsignificant decrease of the safranin O staining 
intensity over time in the cartilage ring (from a semiquantitative score of 2.4 for the freshly 
isolated cartilage to a score of 1.5 at 12 weeks; Figs. 10 and 11A). 
At the interface, there was also a loss of safranin O staining (from 2.3 to 0.9), which reached 
statistical significance for the 8, 10, and 12-week values in comparison to the 0-week values 
(Figs. 10 and 11A). 
In the implant, significantly elevated staining was first noticed at 4 weeks and then reached a 
plateau thereafter (Figs. 10 and 11A; p ≤ 0.05 vs. 0 weeks for 4, 8, 10, and 12 weeks). 





As for the safranin O staining, a largely constant immunostaining for aggrecan was observed in 
surrounding cartilage ring and interface throughout the 12-week culture period (constant scores 
between 1.1 and 1.9 over time; Figs. 10 and 11B). 
Also, substantial staining for aggrecan in the implant was first noticed at 4 weeks and reached a 
plateau thereafter (Figs. 10 and 11A; p ≤ 0.05 vs. 0 weeks for 4, 8, or 12 weeks). Notably, at 4 
and 12 weeks the score for cell-loaded implants was significantly higher than that in cell-free 
implants (compare Figs. 8B and 11B). 
Also, for collagen 2, largely constant immunostaining was observed throughout the 12-week 
culture period in surrounding cartilage ring (scores between 1.9 and 2.2), interface (between 1.6 
and 2.4), and implant (scores between 0.7 and 1.4), without any significant differences among 
the different time points (Figs. 10 and 11C). 
 
 
Figure 10: (Immuno)staining of the collagen implants (cell-loaded) after placement into the inner 
defect of the cartilage rings and subsequent culture for 0, 4, 8, 10, or 12 weeks. Safranin O staining 
and immunostaining for aggrecan, collagen 2, and collagen 1 (for quantification see Fig. 10); staining with 
(isotype-matched) control immunoglobulins consistently yielded negative results. 





Very little immunostaining for collagen 1 (except for one 0-week value, scores mostly between 
0.2 and 0.8) was observed in surrounding cartilage ring, interface, and implant, for the latter with 





Figure 11: Semiquantitative analysis of “host” cartilage, interface, and collagen implants (cell- 
loaded). Score: 0 = no staining, 1 = weak staining, 2 = moderate staining, 3 = strong staining; values are 
shown as means ± standard error of the mean (SEM); symbols indicate p ≤ 0.05 versus * 0 weeks, # 4 
weeks, +10 weeks; § versus cell-free. 
 
 
DMB Assay (Proteoglycan Content; Tissue Extracts and Culture Supernatant) 
 
 
In the cell-loaded cartilage-implant constructs, there was a limited, nonsignificant decrease of 
the GAG content in the surrounding cartilage ring over time with a peak at 4 weeks of in vitro 
culture (from 5485 µg/ml for the freshly isolated cartilage to 4820 µg/ml at 12 weeks; 
intermediate peak of 6373 µg/ml at 4 weeks; Supplementary Figure 1B). 
Interestingly, the GAG content in the surrounding cartilage ring of cell-loaded constructs was 
significantly higher than that of cell-free constructs at all time points (Supplementary Figure 1A 
and B). 
The  chondrocytes  migrated  onto  the  surface  of  the  cartilage  ring  again  showed  an 
approximately 10-fold lower GAG content, with a significant decrease over time (from 449 µg/ml 
for the freshly isolated cartilage to 405 µg/ml at 12 weeks; intermediate peak of 516 µg/ml at 4 
weeks; p ≤ 0.05 vs. 8 weeks for the 10-week time point; Supplementary Figure 1B). There was 





only a marginally lower GAG content in cell-loaded versus cell-free cartilage-implant constructs 
 
(compare Supplementary Figure 1A and B). 
 
In the supernatant, there was a limited decrease of the GAG release over time (from 190 µg/ml 
at 4 weeks to 154 µg/ml at 12 weeks; p ≤ 0.05 vs. 4 weeks for the 8- and 10-week time points), 
as confirmed by a limited, significant decrease of the aggrecan release into the supernatant 
over time (ELISA; from 24 ng/ml at 4 weeks to 10 ng/ml at 12 weeks; p ≤ 0.05 vs. 10 weeks for 
the 12-week time point; data not shown). 
 
ELISA (Collagens 2 and 1; Tissue Extracts and Culture Supernatant) 
 
 
As observed for the cell-free cartilage-implant constructs, there was a limited, nonsignificant 
decrease of the collagen 2 content in the surrounding cartilage ring up to 8 weeks of in vitro 
culture with a slight increase thereafter (from 1580 ng/ml at 0 weeks to 523 ng/ml at 12 weeks; 
Supplementary Figure 1D). The chondrocytes migrated onto the surface of the cartilage ring 
showed an approximately 3-fold higher collagen 2 release than the cartilage ring itself, with a 
nonsignificant, slight decrease over time (from 3234 ng/ml at 0 weeks to 2611 ng/ml at 12 
weeks; Supplementary Figure 1D). Also, there was a limited, nonsignificant decrease of the 
collagen  2  release  into  the  supernatant  up  to 10  weeks  of  culture with  a  slight  increase 
thereafter (from 2115 ng/ml at 4 weeks to 854 ng/ml at 12 weeks; Supplementary Figure 1D). 
In contrast to the collagen 2 release, there was nonsignificant increase of the collagen 1 release 
into the supernatant over time (from 270 ng/ml at 4 weeks to a peak of 429 ng/ml at 10 weeks 
and a subsequent plateau; data not shown). 
 
Gene Expression for Aggrecan, Collagen 2, and Collagen 1 (qRT-PCR) 
 
 
Whereas aggrecan expression in cartilage ring and implant rose to a transient peak at 8 weeks 
of 10-fold and 6-fold, respectively, and thereafter decreased again, aggrecan expression in the 
surface cells was constant over time (Fig. 12A). 
The  collagen  2  expression  in  cartilage  ring  and  surface  cells  was  constant  over  time.  In 
contrast, the collagen 2 expression in the implant rose to a transient peak at 8 weeks of 7-fold 
and thereafter decreased again (Fig. 12B). 
Collagen 1 expression reached a 10-week nonsignificant peak in cartilage ring (10-fold in 
comparison to 0 weeks) and surface cells (30-fold), and a 12-week nonsignificant peak in the 
implant (11-fold; Fig. 12C). 
The aggrecan/collagen 1 ratio in the cartilage ring showed an increase over time with a 12- 
week, 32-fold peak in comparison with 0 weeks. In contrast, the aggrecan/collagen 1 ratio of the 
surface cells and the implant was mostly constant over time (Fig. 12D). 





The collagen 2/collagen 1 ratio in cartilage ring, surface cells, and implant only marginally 









Figure 12: Real time polymerase chain reaction analysis for aggrecan, collagen 1, and collagen 2 
(cell-loaded implants). mRNA expression for aggrecan (A), collagen 2 (B), collagen 1 (C), 
aggrecan/collagen 1 ratio (D) and collagen 2/collagen 1 ratio (E) was determined prior to and after 4, 8, 
10, and 12 weeks of in vitro culture; relative gene expression of the cells located in the “host” cartilage 
matrix (cartilage), on the cartilage surface (cartilage surface), and on/in the collagen implant (implant); 
values are expressed as means ± standard error of the mean (SEM); symbols indicate p ≤ 0.05 versus # 
4 weeks; § versus cell-free. 
 
 
Push-Out Forces of the Cultivated Cartilage-Implant Constructs (Biomechanical Testing) 
 
 
Strikingly, the push-out force for cell-free implants showed a progressive increase during culture 
 
(from 0.002 ± 0.000 N or 2.560 ± 0.680 kPa at 0 weeks to a peak of 0.061 ± 0.056 N or 75.858 
















± 68.780 kPa at 8 weeks and a subsequent plateau; p ≤ 0.05 vs 0 weeks for 4, 8, 10, and 12 
weeks; Fig. 13). 
This was also the case for cell-loaded implants, which showed a progressive increase during 
culture from 0.012 ± 0.007 N (15.026 ± 9.095 kPa) at 0 weeks to a peak of 0.126 ± 0.031 N 
(154.344 ± 38.032 kPa) at 12 weeks (p ≤ 0.05 vs. 4 weeks for 8, 10, and 12 weeks; Fig. 13). At 
any time point, the values for cell-loaded implants were numerically higher than those for cell- 
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Figure 13: Biomechanical push-out testing of the cartilage-implant constructs (cell-free or cell- 
loaded implants). Values are expressed as means ± standard error of the mean (SEM); the symbols 





The aim of the present study was to test the long-term performance (12 weeks) of a collagen 
type 1 hydrogel in a standardized in vitro bovine cartilage punch model. The main findings of the 
study were that: (1) cartilage-implant constructs revealed vital morphology, preserved matrix 
integrity,  progressive,  but  only  slight  proteoglycan  loss  in  the  “host”  cartilage  ring,  and 
decreasing proteoglycan release into the culture supernatant; and (2) cell-free or cell-loaded 
collagen   implants   both   showed   substantial   cell   immigration/colonization,   progressively 
increased levels of aggrecan (mRNA/protein) and collagen 2 (mRNA increasing/protein 
constant), and significantly augmented push-out forces of the implants from the “host” cartilage 
ring over time. Compared with cell-free collagen implants, interestingly, cell-loaded implants 
displayed significantly earlier cell immigration/colonization, earlier and longer lasting deposition 
of aggrecan, and tendentially higher push-out forces. 
The results of the present study are thus in good agreement with the known biocompatibility of 
the already clinically approved CaReS implant, in either cell-free or cell-loaded form, as a 
scaffold material in general and its good performance as an implant material for cartilage repair 





in vitro and in vivo (Efe et al. 2012, Petri et al. 2013, Schneider et al. 2011a, Schuettler et al. 
 
2013, Schuttler et al. 2014). In addition, the study provides in vitro data concerning the dynamic 
molecular processes underlying cartilage regeneration and may be applicable for systematic in 
vitro screening of future cartilage replacement materials. 
As previously published, our present in vitro cartilage regeneration model is highly suitable for 
the testing of chondral implants with proven or expected clinical potential (Dunzel et al. 2013, 
Enders et al. 2009, Hunter und Levenston 2004, Madry et al. 2001, Obradovic et al. 2001, 
Pretzel et al. 2013, Pretzel et al. 2009, Secretan et al. 2010, Vinardell et al. 2009), with easily 
available, ethically unproblematic, and reproducible tissue supply and the possibility of long- 
term in vitro culture for up to 12 weeks without major cartilage degeneration. Modified in vitro 
systems,  including  subchondral  bone  (thus  addressing  the  contribution  of  bone-derived 
secreted factors or progenitor cells) may provide a more complex understanding of the 
performance of the cartilage-bone unit in cartilage regeneration than cartilage only-based 
models. However, such systems may present with technical challenges such as the complete 
removal of the cartilage layer without damage to the subchondral bone lamella (unpublished 
data (Mika et al. 2017, Mika et al. 2011)). 
On  the  other  hand,  cartilage  zones  located  close  to  the  edge  of  the  defect  contained 
proliferation-induced  cell  clusters  as  a  possible  reaction  to  the  initial  mechanical  tissue 
disruption and showed empty chondrocyte lacunae. While these changes may indicate some 
degree of cartilage degeneration in the “host” cartilage (Lotz et al. 2010), they also likely 
suggest an attempt to repair damaged cartilage and seed the cartilage implant (Morales 2007). 
Long-term stability of the “host” cartilage ring over time was indicated by: (1) limited histological 
signs of cartilage degeneration and chondrocyte viability rates of >94% throughout culture; (2) 
limited loss of proteoglycan and stable protein content of collagen 2 (and very small amounts of 
collagen 1); (3) largely constant or even increasing mRNA expression for aggrecan and/or 
collagen 2; and (4) progressively increased anchoring of the implant in the sense of “lateral 
bonding.” This shows that the present system allows long-term in vitro culture, which may yield 
meaningful results with an at least partial transferability to the in vivo situation. 
Both cell-free and cell-loaded cartilage-implant constructs showed substantial colonization of 
the implant, which was paralleled by signs of chondrocyte emigration especially from the 
superficial regions of the “host” cartilage ring. This confirms the high cyto- or biocompatibility of 
the type 1 collagen–based implants in the present in vitro system, as previously reported in 
experimental (Gavenis et al. 2014, Gavenis et al. 2012, Schneider et al. 2011a) and clinical in 
vivo studies (Efe et al. 2012, Schneider et al. 2011b, Schuettler et al. 2013, Schuttler et al. 
2014). Interestingly, cell loading of the collagen implants appeared to accelerate and/or amplify 
the process of cartilage regeneration in the implant, as indicated by significantly faster cell 





colonization. These results argue for an advantage of cell-loaded versus cell-free collagen 
implants, in agreement with earlier studies on cell-seeded or cell-containing implants based on 
collagen or other cartilage replacement materials (Endres et al. 2012, Patrascu et al. 2013, 
Bartz  et  al.  2016,  Zscharnack  et  al.  2015).  Alternatively,  in  vivo  microfracturing  of  the 
subchondral bone plate below the cartilage implant can be used to favor cell immigration into 
initially cell-free implants and optimize the conditions for successful cartilage repair (Erggelet et 
al. 2009, Gavenis et al. 2014, Gavenis et al. 2012). 
Cell-free and cell-loaded collagen implants both showed progressive deposition of the matrix 
molecule aggrecan and a stable protein content of collagen 2 throughout culture, again 
demonstrating  the  cytocompatibility  of  the  implant  material  and  the  active  production  of 
cartilage-specific matrix molecules by vital chondrocytes (Gavenis et al. 2006). This was further 
underlined by the progressively increasing mRNA levels for aggrecan and collagen 2 in the 
implant. 
In   addition,   the   locally  produced,   cartilage-specific   matrix  molecules   appeared   to   be 
successfully retained in the collagen implants, as indicated by a progressive decrease of the 
aggrecan and collagen 2 release into the culture supernatant over time. These results are in 
good agreement with in vitro data obtained with other clinically applied cartilage implants (Bartz 
et al. 2016, Endres et al. 2007, Endres et al. 2012). As discussed above in the context of cell 
immigration, cell loading of the collagen implants accelerated and/or amplified cartilage 
regeneration, as emphasized by a significantly earlier and more long-lasting 
appearance/presence of aggrecan, again supporting an advantage of cell-loaded cartilage 
implants. There were no apparent signs of chondrocyte de-differentiation in either cell-free or 
cell-loaded collagen implants over time, since: (1) cartilage-specific aggrecan protein content 
increased to a plateau at approximately 8 weeks and thereafter; (2) collagen 2 (and collagen 1) 
protein content was stable over time; and (3) the mRNA ratios for aggrecan/collagen 1 and 
collagen 2/collagen 1 were either constant or considerably increased throughout in vitro culture. 
The present in vitro model of cartilage repair may thus provide the local conditions to support 
the phenotypic stability of the chondrocytes in both “host” cartilage and implant. 
The favorable mRNA ratios for aggrecan/collagen 1 and collagen 2/collagen 1 in the implant in 
the present study (an indication for a phenotypic stabilization of the chondrocytes) are in clear 
contrast to the results obtained upon culture of human osteoarthritic or non-osteoarthritic 
chondrocytes in the same collagen implant, but without the surrounding cartilage ring (Halbwirth 
et al. 2015, Jeyakumar et al. 2017, Zwickl et al. 2016, Zwickl et al. 2010). This strongly indicates 
that the present “in situ organ” culture system generates a local milieu favoring the long-term 
preservation  of  the  differentiated  chondrocyte  phenotype,  cartilage  matrix  production,  and 
lateral bonding, a process likely involving reciprocal effects of the cartilage ring and the implant 





on each other (unpublished data). These results are in good agreement with previous reports on 
culture systems applying such a surrounding cartilage ring (Hunter und Levenston 2004, 
Obradovic et al. 2001, Secretan et al. 2010, Vinardell et al. 2009), but are addressed for the first 
time on a molecular level in the current study. 
Both cell-free and cell-loaded collagen implants showed significantly increased push-out forces 
from the “host” cartilage ring over time, with tendentially higher values for cell-loaded implants. 
Thus, well maintained cell vitality, substantial cell migration, and sustained local matrix 
production appear to have functional consequences in the sense of augmented lateral bonding 
of the implant to the surrounding “host” cartilage. Lateral bonding at the cartilage-implant 
interface and the resulting push-out forces are likely influenced by various factors, including: (1) 
the character of the tissue formed at the interface (Moretti et al. 2005); (2) sprouting of extra- 
cellular matrix components in the interfacial zone; and (3) the presence or absence of cell death 
at the interface (Theodoropoulos et al. 2011). 
The increase of the push-out forces during the 12-week culture for cell-free or cell-loaded 
collagen implants (from 2.560 to 54.259 kPa or from 15.026 to 154.344 kPa, respectively) led to 
final values, which are comparable to those previously reported for poly(glycolic acid)-construct 
tissues after 5 weeks of culture (Hunter und Levenston 2004) or for cell-loaded agarose 
hydrogels (Vinardell et al. 2009). This shows that collagen implants, in either cell-free or cell- 
loaded form, may be well suitable as a scaffold material in general and as an implant material 
for cartilage repair in vivo (Efe et al. 2012, Schneider et al. 2011b, Schuettler et al. 2013, 
Schuttler et al. 2014). 
The method applied in the present study to measure the push-out force of the collagen implants 
for the first time took into consideration the blank value obtained by a second push-through of 
the indenter after the initial push-out of the implant. This approach may help to obtain 
reproducible  results  by  addressing  technical  artifacts  due  to  factors  such  as  differences 
between the defect sizes in individual samples or variations of the implant hydrogel diameter 






In the present in vitro bovine cartilage punch model, largely preserved tissue integrity, limited 
proteoglycan release, as well as progressively increasing cartilage differentiation and push-out 
forces (for up to 12 weeks of cultivation) suggest initial cartilage regeneration and imply lateral 
bonding of the current collagen implant to the surrounding cartilage. On the basis of significantly 
faster cell colonization and a significantly earlier and more long-lasting appearance/presence of 
aggrecan, cell-loaded implants may show an advantage over cell-free cartilage implants. The 





present in vitro cartilage regeneration model thus proved well suitable to demonstrate the 
regenerative  capacity  of  this  clinically  approved  hydrogel  collagen  type  1  implant  and  to 
decipher some of the underlying molecular processes. 
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The suitability of near-infrared spectroscopy (NIRS) for non-destructive measurement of 
cartilage thickness was compared with the gold standard needle indentation. A combination 
of NIRS and biomechanical indentation (NIRS-B) was used to address the influence of 
varying loads routinely applied for hand-guided NIRS during real-life surgery on the accuracy 
of NIRS -based thickness prediction. 
NIRS-B was performed under three different loading conditions in 40 osteochondral cylinders 
from the load-bearing area of the medial and lateral femur condyle of 20 cadaver joints (left 
stifle joints; female Merino sheep; 6.1 ± 0.6 years, mean ± standard error of the mean). the 
cartilage thickness measured by needle indentation within the region analyzed by NIRS -B 
was then compared with cartilage thickness prediction based on NIRS spectral data using 
partial least squares regression. 
NIRS-B repeat measurements yielded highly reproducible values concerning force and 
absorbance. Separate or combined models for the three loading conditions (the latter 
simulating load-independent measurements) resulted in models with optimized quality 
parameters (e.g., coefficients of determination R2 between 92.3 and 94.7) and a prediction 
accuracy of < 0.1 mm. 
NIRS appears well suited to determine cartilage thickness (possibly in a hand-guided, load- 
independent  fashion),  as  shown  by  high  reproducibility  in  repeat  measurements  and 
excellent reliability compared with tissue-destructive needle indentation. This may provide 
the basis for non-destructive, intra-operative assessment of cartilage status quo and fine- 
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Traumatic and osteoarthritis (OA) cartilage defects show limited regeneration capacity, 
aggravated by secondary loss of cartilage substance in the adjacent tissue. A number of 
surgical techniques are currently used to repair such cartilage defects (Niemeyer et al. 2013, 
Steinwachs et al. 2008). However, as they are mostly not curative, there is a continuing need 
to optimize the approaches, for example, by using large animal models to verify specific 
aspects of the interventions. Intra-operative mapping of cartilage thickness with high regional 
resolution  by  non-destructive  near-infrared  spectroscopy  (NIRS)  may  be  superior  to 
previously applied, non-invasive, high-quality magnetic resonance imaging (MRI) and may 
thus allow fine-tuning of repair procedures for articular cartilage injury, for example, a more 
precise definition of the defect borders. 
In animal models, the gold standard for the determination of cartilage thickness is the method 
of invasive, tissue-destructive needle indentation (Jurvelin et al. 1995), and only a limited 
number of studies report on non-invasive procedures such as MRI (Roemer et al. 2009), 
ultrasound (Suh et al. 2001), or NIRS (Afara et al. 2012, Afara et al. 2013a, Afara et al. 
2013b, Hoffmann et al. 2012 , Plettenberg 2007, Tiderius et al. 2007). Thus, there is a high 
need for non-destructive and convenient techniques to analyze the thickness of healthy or 
diseased articular cartilage in preclinical and human set-ups. 
NIRS has been previously applied for the non-destructive assessment of normal or 
degenerated cartilage in porcine, ovine, equine, rat, and bovine animal models (Afara et al. 
2012, Afara et al. 2013b, Hoffmann et al. 2012 , Plettenberg 2007), in tissue-engineered 
cartilage constructs (Baykal et al. 2010), and for the quantification of cartilage alterations in 
degenerative human OA (Stumpfe et al. 2013, Tiderius et al. 2007). In these studies, NIRS 
showed good correlations with clinical injury scores, biomechanical properties (Stumpfe et al. 
2013), histological grading (Stumpfe et al. 2013), and biochemical features. NIRS may thus 
be suitable as a non-destructive, clinically applicable method for cartilage analysis, also 
considering  that  Afara  et  al  (Afara  et  al.  2013a)  have  already  used  NIRS  for  the 
determination of the articular cartilage thickness under static conditions. 
The present study aimed at determining the accuracy of NIRS-based cartilage thickness 
prediction and the influence of varying loads and/or data preprocessing. A specific and novel 
approach of this study was to perform the measurements under non-static conditions. For 
this purpose, a combination of NIRS and biomechanical indentation (NIRS-B) was used, as 
previously established in our group (Hoffmann et al. 2012 , Hoffmann et al. 2010). This 
combined approach was chosen to address the question of whether ex vivo non-destructive 
NIRS is suitable for the determination of cartilage thickness in a force-independent fashion, 
which takes into account the varying loads during hand-guided NIRS. This may then 
eventually provide the basis for intra-operative assessment of cartilage status quo in humans 





and experimental models. In the present study, NIRS-B was thus successfully applied for the 
first time to predict the cartilage thickness on the femur condyles in the large animal model 
sheep, and to validate it by comparison with the gold standard indentation and the values 
obtained by histology. 
 
Materials and Methods 
 
 
Sample Preparation Method 
 
 
Twenty left cadaver stifle joints (adult female Merino sheep; age 6.1 ± 0.6 years (mean ± 
standard error of the mean [SEM]; body weight 78.5 ± 2.7 kg; frozen at −20°C) without 
cartilage alterations were used. The joint samples were derived from either unpublished 
studies of experimental chondral repair (permission from the governmental commission for 
animal protection, Free State of Thuringia, Germany; registration number 02-007/11) or 
published studies on the injection of calcium phosphate cement into bone defects of lumbar 
vertebral bodies (Bungartz et al. 2016, Maenz et al. 2017). 
After thawing (24 hours), the joints were opened, the femur was fixed in a clamp, and the 
cartilage kept humid with isotonic saline solution. One osteochondral cylinder each (diameter 
10 mm; depth ~20 mm; original orientation on the condyle marked by an incision) was 
extracted with a trepan drill from the main load-bearing area of the medial and lateral femur 
condyle (Fig. 14A-D), visually examined for approximately equal cartilage thickness along its 
circumference, transferred to isotonic saline solution, and stored at 20°C until further analysis 
(within 30 minutes). 
 
 
Figure 14: Sample preparation (left knee). One osteochondral cylinder each (diameter 10 mm; 
depth 20 mm) was extracted with a trepan drill form the main load-bearing area of the medial and 
lateral femur condyle (A) for subsequent near-infrared spectroscopy (NIRS) (B; × = center of fiber 
probe), needle indentation at 5 defined locations covering the region analyzed by NIRS (C), and 
conventional histology at 3 different levels representing the locations analyzed by NIRS and needle 
indentation (D). 







Combination of NIRS and Biomechanical Indentation (NIRS-B) 
 
 
NIRS-B was performed on the cartilage surface of the osteochondral cylinders (Fig. 14B) in a 
climatized room (20°C) using a NIRS system (Arthrospec; Jena, Germany). As shown in 
Supplementary Figure 2, this system was synchronized with a linear translation stage 
(Thorlabs, Dachau, Germany) driving a 2-mm diameter fiber probe and a force sensor (ME 
Systeme, Hennigsdorf, Germany) to simultaneously measure indentation force (force range 
0-10 N; sampling rate 32 Hz) and corresponding tissue NIRS absorbance spectra (range of 
 
947-1649 nm; spectral resolution 3 nm; dynamic range 16 bit; sampling rate of 9 Hz) 
(Hoffmann et al. 2012 ). 
Thirty minutes after warm-up, the NIRS-B system was calibrated using a 
polytetrafluoroethylene (PTFE) optical reference standard. Subsequently, the osteochondral 
cylinders were placed in the sample holder and immersed in isotonic saline until the cartilage 
surface was covered. 
NIR spectra of 40 samples were acquired for unloaded cartilage (interval 1, minimal 
indentation), loaded cartilage (interval 2, indentation 0.1 mm) and loaded cartilage after 
relaxation (interval 3, indentation 0.1 mm) as shown in Figure 15. These 3 load conditions 
were chosen to represent the forces occurring during hand-guided, intraoperative NIRS 
assessment when: (1) just lightly touching the  surface; (2) applying variable forces during 
locus screening (“navigation force”) or actual quantitative measurement (“procedure force” 
(Chami et al. 2006, Plettenberg 2007)); or (3) assessing cartilage relaxation during more 




Figure 15: Movement of the fiber probe during the NIRS-B (near-infrared spectroscopy in 
combination with biomechanical indentation) measurements. The position of the fiber probe 
during the NIRS measurements is shown in relation to the surface of the osteochondral samples 
(position 0); the intervals 1 (minimal indentation), 2 (maximal indentation), and 3 (relaxation), in which 
NIRS spectra were recorded, are also indicated. 
 
 
Each measurement sequence started by lowering the fiber probe onto the surface of the 
sample with a speed of 0.2 mm/s to reach the feed position s = 0 mm, as defined by F0 = 0.5 
N. After recording 10 NIR spectra in this minimal load position (interval 1; Fig. 15), the fiber 





probe was removed for a 30-second sample resting period and then advanced toward the 
sample surface with a speed of 0.2 mm/s until maximal indentation of 0.1 mm was reached. 
At this point, 10 NIR spectra and the indentation force Fmax  were recorded (interval 2; Fig. 
15). The indentation depth was chosen in the present set-up, since the application of a 
 
specified strain as a percentage of the cartilage thickness was impossible in undamaged 
cartilage of unknown thickness (i.e., without prior needle indentation). 
After a relaxation time of t = 180 seconds with no probe movement, further 10 NIR spectra 
and the indentation force FRelax were recorded (interval 3; Fig. 15). The 10 spectra of each 
interval were averaged and the absorbance was calculated as A = −log10 (Sample Signal – 
Dark Signal/Reference Signal – Dark Signal). 
To determine the reproducibility of NIRS-B measurements, 3 repeat measurements were 
conducted on one sample, using a cartilage relaxation period of approximately 1 minute 
between individual measurements to reduce reswelling artifacts. 
The spectral data set acquired under all 3 loading conditions (complete range of wavelengths 
from 947 to 1649 nm; exemplary depiction of the loadings and factor weights of several 
principal components based on the factor analysis of one NIR spectra shown in 
Supplementary Fig. 3) and the reference thickness set determined by needle indentation or 
histology (location 5 on the respective condyle; Fig. 14C and D) of all 40 cartilage samples 
were then used to develop calibrations. In the case of the spectra from interval 1 (virtually 
unloaded cartilage), calibration was performed using the original reference thickness set, in 
the case of spectra from intervals 2 and 3 (constant indentation depth 0.1 mm), 0.1 mm were 
subtracted from the reference thickness values. 
The Bruker OPUS 7.0 software was then used for data pre-processing, partial least squares 
(PLS) regression, and leave-one-out cross validation. PLS was preferred in the present study 
because: (1) it is the standard method for NIRS analysis; (2) due to its widespread use, it 
favors comparability of the data with other publications in the field; and (3) it prepares the 
ground for future applications with a higher number of parameters such as varying tissue 
features (including unhealthy tissue), temperatures, feeds, and so on. 
The resulting PLS models were evaluated and optimized on the basis of the parameters 
coefficient of determination (R2; maximum of 100) (Haaland und Thomas 1988), root mean 
square error of cross validation (RMSECV) (Haaland und Thomas 1988), residual prediction 
deviation (RPD; with values < 2.5 classified as poor and not recommended for screening), 
and number of principal components (rank; desirable rank between 3 and 9 to avoid 
underfitting or overfitting) (Haaland und Thomas 1988). The RPD is the ratio of the standard 
deviation to the standard error of prediction, and is a common quality parameter routinely 
used in NIR spectroscopy. 





To investigate the influence of varying loads, either models based on separate spectra from 
intervals 1, 2, and 3 (models 1-3, respectively; 40 spectra each), or based on combined 
spectra from all 3 intervals (model 4; 120 spectra), were developed. 
To investigate the influence of noise reduction, modeling was fully repeated with spectral 
data previously smoothed using a pixel weighted mean filter, resulting in 8 models each for 






Cartilage thickness was validated at 5 different locations on each specimen (Fig. 14C), 
covering the region analyzed by NIRS (Suh et al. 2001). A hypodermic needle (25 G; 0.5 × 
16 mm; Sterican; B. Braun Melsungen AG; Melsungen; Germany) was driven through the 
cartilage by a linear servomotor at a constant speed (0.3 mm/s) while continuously recording 
force  and  position.  Cartilage  thickness  was  determined  as  the  distance from  the  initial 
surface contact to the tidemark, as defined by a characteristic change in the curve slope due 
to the different material properties of uncalcified and calcified cartilage (Supplementary Fig. 






Immediately after performing NIRS-B and needle indentation, the osteochondral cylinders 
were fixed in 4% paraformaldehyde, decalcified in Osteodec solution for 3 weeks (Bio- 
Optica, Milan, Italy; weekly exchange of the solution), dehydrated, and embedded in paraffin. 
The samples were then cut into 8-µm sections and stained with hematoxylin and eosin. 
The  thickness  of  the  articular  cartilage  (tidemark  to  surface)  at  the  locations  of  all 
NIRS/needle indentation measurement points (see Fig. 14B-D) was measured in the 
respective location of one paraffin section each using an Axiophot microscope, a 4 × EC 
Plan-Neofluar objective (both Carl Zeiss, Jena, Germany) and the Axiovision 4.2. software 





Results (means ± SEM) were statistically analyzed using the Wilcoxon signed rank test and 
SPSS 22.0 (IBM SPSS, Armonk, NY, USA). Correlations among parameters were assessed 
using the Spearman rank correlation test. Statistical significances were accepted at p ≤ 0.05. 








This section presents representative full NIRS spectra and describes the data from the NIRS- 
B assessment and its reproducibility. It then shows the results from the gold standard 
determination of the cartilage thickness by needle indentation (or histology), and, finally, it 
reports on the development of models for the prediction of cartilage thickness by NIRS on the 
basis of values derived from either needle indentation or histology. 
 
Full NIRS Spectrum Depiction 
 
 
Full NIRS spectra show the characteristic wavelength pattern of three repeat measurements 
for one cartilage sample in interval 1 (minimal indentation; F0= 0.5 N) with maxima at λ = 950 
nm (second overtone of O-H bonds), λ = 1170 nm (second overtone of C-H, C-H2, and C-H3 
bonds), and λ = 1450 nm (first overtone of O-H bonds; Fig. 16; for the depiction of the 
spectra of either the same location under the influence of the different loads at the different 
intervals or in cartilage samples of varying thickness see Supplementary Figs. 5 and 6, 
respectively). Low variability of the data, exemplified for the low-noise wavelength of 950 nm 




Figure 16: Near-infrared spectroscopy (NIRS) absorbance spectrum in interval 1 (minimal 
indentation; F0 = 0.5 N). The complete NIRS absorbance spectrum of 3 repeat measurements for one 
cartilage sample in interval 1 displays the characteristic wavelength pattern of cartilage with maxima at 
λ = 950 nm, λ = 1170 nm, and λ = 1450 nm. In subsequent Figures 17B and 18B, the variability of the 
absorbance data is exemplarily depicted for the characteristic low-noise wavelength of 950 nm (see 
insert). 





In subsequent Figures 17B and 18B, the variability of the absorbance data is exemplarily 
depicted for the characteristic low-noise wavelength of 950 nm (see insert). 
 
Reproducibility of NIRS-B Measurements 
 
 
Repeated measurements of the cartilage in one sample (sheep 3) yielded highly reproducible 
values for force (Fmax, and FRelax; SEM maximum 4.4% of the mean; Fig. 17A; Table 2) and 
absorbance in intervals 1 to 3 at the positions minimal indentation (s = 0), maximal 









Figure 17: Accuracy of NIRS-B (near-infrared spectroscopy in combination with biomechanical 
indentation) repeat measurements. (A) Three-dimensional force-feed-time graph of triple repeat 
measurements in one sample; (B) change of absorbance at the wavelength of λ = 950 nm in triple 
repeat measurements in one sample; after numerically higher absorbance values in interval 1, the 
values slightly increased in the period between intervals 2 and 3, in parallel with a numerically 





Reproducibility of NIRS-B: Three repeat measurements of force and absorbance on one sample in 
intervals 1, 2, and 3, exemplified for λ = 950 nm 
 






 F0 (N) Fmax (N) FRelax (N) at 950 nm at 950 nm at 950 nm 
1 0.50 3.05 0.75 0.4345 0.4186 0.4221 
2 0.50 3.16 0.79 0.4327 0.4180 0.4198 
3 0.50 3.36 0.87 0.4283 0.4147 0.4184 
Mean  3.19 0.80 0.4319 0.4171 0.4201 
SEM  0.09 0.04 0.0018 0.0012 0.0011 
SEM/mean 
(%) 
2.8 4.4 0.4 0.3 0.3 





The unloaded tissue in interval 1 showed a numerically higher absorbance than the loaded 
tissue in intervals 2 and 3. The absorbance slightly increased between intervals 2 and 3, 
whereas the force decreased from Fmax to FRelax (Fig. 17A and B; Table 2). 
NIRS-B assessment. Indentation force and complete NIRS spectra (947-1649 nm) of 40 
 
samples were then measured in one defined location on the load-bearing area of the medial 
and lateral femur condyle (see Fig. 14) in intervals 1, 2, and 3 (Fig. 15). During cartilage 
surface compression in interval 2, the force significantly increased (2.19 ± 0.23 N) and then 
significantly decreased again (0.59 ± 0.06 N) toward the end of the relaxation period (interval 




Figure 18: NIRS-B (near-infrared spectroscopy in combination with biomechanical indentation) 
measurements of all samples. (A) Three-dimensional force-feed-time graph of all samples (n = 40); 
(B) change of absorbance at the wavelength of λ = 950 nm in all samples; with variable values for the 
absorbance of the 40 individual samples, the force increased during compression of the cartilage 
surface in interval 2, and then decreased again at the end of the relaxation period (interval 3). In 
contrast, the absorbance significantly decreased during initial compression, and significantly increased 
until the end of the relaxation period. 
 
 
Interval 1 (minimal indentation) showed variable NIRS absorbance (exemplified for λ = 950 
nm; mean of 0.3459 ± 0.0119 AU; Table 3). In contrast to the force pattern, the absorbance 
significantly decreased during the initial compression (interval 2), and then significantly 
increased until the end of the relaxation period (Fig. 18B; Table 3). 







NIRS-B measurement: Force and absorbance (exemplified for λ = 950 nm) of 40 cartilage samples 
measured in intervals 1, 2 and 3; + = p ≤ 0.05 in comparison to F0   or AInterval   1; * = p ≤ 0.05 in 
comparison to Fmax or AInterval 2. 
 






 F0 (N) Fmax (N) FRelax (N) at 950 nm at 950 nm at 950 nm 
Mean 0.5 2.19+ 0.59* 0.3459 0.3276+ 0.3331* 
SEM  0.23 0.06 0.0119 0.0117 0.0119 
(min;max)  (0.88;6.68) (0.24;2.40) (0.2169; (0.2137; (0.1976; 
    0.5448) 0.5251) 0.5308) 
SEM/mean  10.5 10.2 3.4 3.6 3.6 
(%)       
 
 
Needle   indentation.   Cartilage   thickness   showed   regional   heterogeneity   for   the   5 
measurement points on the medial and lateral femur condyles (n = 20 each; Fig. 19A and B; 









Figure 19: Determination of cartilage thickness by needle indentation (n = 40). Cartilage 
thickness at the 5 measurement locations on the medial femur condyle (A) and the lateral femur 
condyle (B). Values shown are means ± standard error (SEM) of the mean for each location, as well 
as those for all locations). The symbols indicate p ≤ 0.05 in comparison with: * measurement point 1 
(lateral-distal); # measurement point 2 (medial-distal); + measurement point 3 (medial-proximal); & 
measurement point 4 (lateral-proximal); and § medial femur condyle. 
 
 
The cartilage thickness of all 5 measurement points on each condyle was averaged for 
comparison with subsequent NIRS-B; the overall mean for the medial condyle (1.14 ± 0.07 
mm) was significantly higher than that for the lateral condyle (0.78 ± 0.05 mm; Fig. 19A and 
B). 





On the medial condyle, the values for measurement point 3 were significantly lower than 
those for measurement points 1, 2, 4, and 5 (p ≤ 0.05); in addition, measurement points 2, 4, 
and 5 showed significantly lower values than measurement point 1 (Fig. 19A). 
On the lateral condyle, the values for measurement point 4 were significantly lower than 
those for measurement points 2, 3, and 5 (Fig. 19B); in addition, measurement points 2, 3, 
and 5 showed significantly higher values than measurement point 1, and measurement point 
5 (central) showed significantly lower values than measurement point 2 (Fig 19B). 
 
 
NIRS-B Thickness Prediction Based on Needle Indentation 
 
 
For all 8 models, a prediction accuracy of < 0.1 mm and models with highly optimized quality 
parameters were obtained (R2  from 92.43 to 94.74; RMSECV < 0.1; optimized values for 
RPD between 3.8 and 4.4; acceptable number of principal components between 4 and 10). 
Performance of models with raw or smoothed data was comparable (i.e., noise did not cause 
substantial deterioration of the models; Table 4), indicating that non-modified data can be 
used for future analyses. Correlations between NIRS and needle indentation values for the 
different models were also highly significant (rho between 0.953 and 0.967; all P = 0.000; 
Fig. 20). 
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Figure 20: Correlations between the values obtained by near-infrared spectroscopy (NIRS) and 
needle indentation. Visual depiction of the correlations between the values obtained by NIRS and 
needle indentation for the different prediction models (including rho, P, and n for each correlation; 
compare with Table 4). 
 
 
Regarding differences among the thickness predictions for individual cartilage samples 
derived from the 3 models for the different loading conditions, and from model 4 based on all 
3 conditions (total of n = 6 prediction values for each sample), the variability was very limited 
 
(SEM between 0.9% and 5.7% of the mean; data not shown). 







NIRS-B thickness prediction based on needle indentation (minus 0.1 mm offset for intervals 2 
and 3; measurement point 5): Evaluation of (n = 40) samples. Coefficient of determination (R2), Root 
Mean Square Error of Cross Validation (RMSECV), Residual Prediction Deviation (RPD), and number 
of principal components (Rank); calibrations were either based on the separate use of 40 spectra each 




RMSECV RPD No. of principal 
components 
(Rank) 
No. of spectra 
(data source) 
Model 1r raw 94.04 8.61 4.1 5 40 (A1) 
 Model 1s   smoothed  94.12  8.57  4.1  4  40 (A1) 
Model 2r raw 94.09 8.59 4.12 4 40 (A2) 
 Model 2s   smoothed  94.74  8.10  4.36  8  40 (A2) 
 Model 3r raw 92.43 9.72 3.64 4 40 (A3) 
 Model 3s smoothed 92.94 9.39 3.76 10 40 (A3) 
 Model 4r raw 93.63 9.00 3.96 9 120 (A1, A2, A3) 
 Model 4s smoothed 93.91 8.80 4.05 8 120 (A1, A2, A3) 
 
 
Independently  performed  linear  regression  analysis  for  repeated  measures  confirmed  a 
highly significant, positive correlation between needle indentation and NIRS-B in model 4 (n 
= 120; P ≤ 2.2 × 10-16; R2 = 0.958; Supplementary Figure 7B), confidence intervals close to 
 
the prediction accuracy of NIRS-B (approximately 0.17 mm; Supplementary Fig. 7A), and 
showed no significant indications for an offset of the values for the 2 methods from zero 
(Supplementary Fig. 7B), a significant inter observer variability (Supplementary Fig. 7B), or a 





As observed by needle indentation, the histologically determined cartilage thickness for the 5 
measurement points on the medial and lateral femur condyles (n = 20 each) showed regional 
heterogeneity (see legend to Fig. 21A and B). 
When the cartilage thickness of all 5 measurement points on each condyle was averaged, 
the overall mean value for the medial condyle (0.91 ± 0.04 mm) was significantly higher than 
that for the lateral condyle (0.63 ± 0.03 mm; Fig. 21A and B). 
The histology values resulted significantly lower than the needle indentation values for 
measurement points 1, 4, and 5 on the medial condyle and for measurement points 2, 3, and 
5 on the lateral condyle (Fig. 21A and B). However, there was a weak, but significant 
correlation between the thickness values derived from histology and needle indentation on 
both condyles (rho 0.544 and 0.367, respectively; Fig. 21C and D). 







Figure 21: Comparison between the cartilage thickness values obtained by histology and 
needle indentation (n = 40 for all measurement points). Cartilage thickness at the various locations 
on the medial femur condyle (A) and the lateral femur condyle ([B; data shown as means ± standard 
error (SEM) of the mean for each location, as well as those for all locations]); Spearman rank 
correlations between the values obtained by needle indentation and histology on the medial (C) and 
lateral condyle (D); P ≤ 0.05 in comparison with: * measurement point 1; # measurement point 2; + 
measurement point 3; & measurement point 4; § medial femur condyle; and $ for the comparison 
between needle indentation and histology. For reasons of clarity, significant differences among the 
needle indentation values for the individual measurement points are not shown in this figure, but only 
in Figure 19 (see above). 
 
 
On the medial condyle, the values for measurement point 3 were significantly lower than 
those for measurement point 2 (p ≤ 0.05); in addition, measurement point 4 showed 
significantly lower values than measurement points 1, 2, and 5, and measurement point 2 
showed significantly higher values than measurement points 1 and 5 (Fig. 21A). 
On the lateral condyle, the values for measurement points 3 and 4 were significantly lower 
than those for measurement point 1; in addition, the values for measurement points 4 and 5 
were significantly higher than those for measurement point 3 (Fig. 21B). 
 
NIRS-B Thickness Prediction Based on Histology 
 
 
When using histology as a reference set, a high prediction accuracy (< 0.1 mm), good-quality 
parameters (R2 from 86.44 to 90.84; RMSECV ≤ 0.1; acceptable number of principal 
components; Table 5), and significant correlations were obtained for models 1, 2, and 4 (rho 
between 0.900 and 0.936; all P = 0.000; Supplementary Fig. 8). 









NIRS-B thickness prediction based on histology (minus 0.1 mm offset for intervals 2 and 3; 
measurement point 5): Evaluation of (n = 40) samples. Coefficient of determination (R2), Root Mean 
Square Error of Cross Validation (RMSECV), Residual Prediction Deviation (RPD), and number of 
principal components (Rank); calibrations were either based on the separate use of 40 spectra each 






RPD No. of principal 
components 
(Rank) 
No. of spectra 
(data source) 
Model 1r Raw 90.37 8.57 3.23 7 40 (AI1) 
  Model 1s  Smoothed  90.57  8.48  3.3  9  40 (AI1) 
Model 2r Raw 86.76 10.00 2.77 8 40 (AI2) 
Model 2s Smoothed 86.44 10.20 2.72 6 40 (AI2) 
Model 3r Raw 89.39 8.99 3.07 9 40 (AI3) 
Model 3s Smoothed 89.76 8.83 3.13 10 40 (AI3) 
Model 4r Raw 91.36 8.23 3.4 8 120 (A1, A2, A3) 
Model 4s Smoothed 90.84 8.47 3.31 9 120 (A1, A2, A3) 
 
 
Lack of improvement after data smoothing again indicated the principal suitability of non- 
modified data (Table 5). Instead, model 3 based on NIRS absorbance during relaxation 





In the present study, aimed at determining the accuracy of NIRS-based thickness prediction 
under the influence of varying loads using a combination of NIRS and biomechanical 
indentation (NIRS-B), NIRS-B proved highly reproducible in measuring the absorbance of 
normal articular cartilage in different states of compression or relaxation. Following 
development of optimized data analysis models in comparison with the articular cartilage 
thickness determined by needle indentation (and, to a lesser degree, also in comparison with 
histology), NIRS-B was capable of predicting the articular cartilage thickness with a high 
accuracy (< 0.1 mm). Thus, non-destructive, force-independent NIRS-B appears highly 






Repeated measurements of the cartilage yielded highly reproducible values with very limited 
variation for force and absorbance levels throughout the NIRS-B assessment protocol. This 
result shows that NIRS-B yields stable and reliable experimental results, and further confirms 
the methodological validity of combined NIRS analysis and biomechanical indentation, as 





previously suggested by our group and others (Hoffmann et al. 2012 , Hoffmann et al. 2010, 
Sugisaki et al. 2001). 
 
Time Course of Force and Absorbance 
 
 
When compressing the cartilage on the femur condyle during indentation with the NIRS fiber 
probe, the force increased to a maximum (Fmax; 2.19 N) and subsequently decreased again 
toward the end of the relaxation period (Frelax; 0.59 N). This well-known cartilage stress- 
relaxation phenomenon (Sophia Fox et al. 2009), previously observed using force 
measurements (Hoffmann et al. 2012 ), NIRS (Hoffmann et al. 2012 ), and ultrasound 
(Nieminen et al. 2006, Zheng et al. 2005), is also reflected in an initial decrease of the 
absorbance during maximal indentation of s = 0.1 mm and a subsequent increase between 
intervals 2 and 3. The initial decrease of NIRS absorption during maximal indentation likely 
results from the extrusion of water (the main absorber of NIR radiation) from the cartilage 
extracellular matrix (Hoffmann et al. 2012 , Padalkar et al. 2013). However, the increasing 
NIRS absorption during subsequent cartilage relaxation is partially unexpected, since the 
cartilage should continue to lose water under continuous compression, as confirmed by a 
progressive decrease of the compression forces. 
However, a compressed extracellular matrix and/or a partial loss of chemically bound, fixed 
water from collagens or glycosaminoglycan side chains (GAGs) of cartilage proteoglycans 
(see Padalkar et al. (Padalkar et al. 2013) and references therein) may also underlie the 
increasing NIRS absorption in this phase. Finally, such “water-reduced” GAGs may partially 
revert the extrusion of water from the cartilage and cause an osmotically driven influx of 
water (Hoffmann et al. 2012 , Padalkar et al. 2013). 
The existence of free and bound water in the cartilage matrix, as well as their differential 
detection  by  bands  of  different  wavelengths  in  static  NIRS,  has  been  demonstrated 
previously (Bagratashvili et al. 1997, Padalkar et al. 2013, Ressler et al. 1976). It remains to 
be shown whether such differential detection of free and bound water is also applicable to 
the dynamic combined NIRS-B protocol performed in the present study, and whether further 
biochemical analysis can identify the specific molecules undergoing an alteration of their 
NIRS signal under these conditions. 
 
NIRS-B Thickness Prediction 
 
 
In the present study, suitable calibration algorithms were developed for the comparison of the 
dynamic NIRS-B and needle indentation data using PLS regression. This resulted in robust 
models with a high accuracy for the prediction of the articular cartilage thickness (< 0.1 mm). 





These results confirm previous high-accuracy findings of Afara et al. (Afara et al. 2012, Afara 
et al. 2013a) with static NIRS. However, these authors mounted fiber probe and specimen in 
a rig to keep both components stable and avoid vibrations during NIRS, a setup difficult to 
achieve during manual application in arthroscopic surgery. In the latter case, a standard hook 
probe is pressed on the tissue surface with forces between 0.5 and 4 N (Chami et al. 2006, 
Plettenberg 2007), a range well covered in the present study. Thus, the current study 
demonstrates for the first time that, at an experimental level, prediction of cartilage thickness 
can not only be performed by static NIRS but also by dynamic combined NIRS-B. 
The models based on separate data from intervals 1 to 3 (constant load, 40 spectra each) 
and the model 4 based on all 3 intervals (varying load, 120 spectra) all showed high quality 
parameters. Notably, model 4 combining data with largely varying forces (range 0.5-6.68 N) 
also showed high performance, indicating that exact prediction of cartilage thickness by 
NIRS-B may also be feasible under intraoperative, hand-guided conditions. This may more 
closely reflect real-life surgery, during which different surgeons apply a fiber probe with 
variable forces during locus screening  (“navigation force”)  or actual quantitative 
measurement (“procedure force” (Chami et al. 2006, Plettenberg 2007)). Also, model 
performance was largely unchanged by data smoothing, indicating that more easily available 
raw data without any loss of information can be used for future analyses. 
One particular example for NIRS-B thickness prediction based on needle indentation is now 
depicted in Supplementary Figure 3, in which 5 individual factors with their respective factor 
weights contribute to the prediction model (model 2s, smoothed; coefficient of determination: 
48.32%, 82.42%, 87.62%, 89.88%, 91.64% for 1, 2, 3, 4, and 5 factors, respectively). Since 
this  contribution  is  mainly  situated  in  the  wavelength  range  around  1170  nm  (second 
overtone of C-H, C-H2, and C-H3  bonds), it can be speculated that NIRS signal changes 
reflect alterations of the main organic components of cartilage, that is, large aggregating 
proteoglycans and collagens. In this case, changes in water content appear to be less 
important, since the 2 main water peaks at 950 and 1450 nm are not included. Thus, NIRS-B 
thickness  prediction  may  be  based  on  differences  in  matrix  content  and/or  distribution 
between the NIRS probe on the cartilage surface and the NIR-reflecting border to the 
subchondral lamella in cartilage of varying thickness. However, it is has to be clearly pointed 
out that: (1) NIR spectra reflect numerous, very broad, and strongly superimposing overtone 
and combination bands; (2) cartilage contains a multitude of organic and inorganic 
components, including up to 70% of water; (3) the NIR bands in the cartilage cannot be 
directly interpreted, but must be analyzed using complex statistical approaches. The 
conversion of such speculations to scientific insight into the molecular basis of the NIRS 
signal changes will thus require much more detailed NIR spectra of aqueous solutions with 





defined concentrations of one or few organic components and their respective NIRS profiles 
(Zierbock et al. 2012). As in the case of the needle indentation-based models, the histology- 
based NIRS model 4 showed high performance (RPD >3.3), further underlining that dynamic 
NIRS is in principle able to predict cartilage thickness under intra-operative, hand-guided 





Marked regional heterogeneity of the cartilage thickness was observed on both medial and 
lateral femur condyles, with individual values for the medial condyle from 0.51 mm (medial- 
proximal) to 1.89 mm (lateral-distal; overall mean 1.14 ± 0.07 mm) and values for the lateral 
condyle from 0.35 mm to 1.29 mm (both lateral-proximal; overall mean 0.78 ± 0.05 mm). 
To our knowledge, measurements of cartilage thickness on the medial and lateral femur 
condyle  in sheep  by needle indentation have  not  been published before;  however,  the 
present values were well in the range of those obtained by conventional formalin/paraffin 
histology (Ruediger et al. 2013, Cake et al. 2003). This confirms that, apart from its 
invasiveness, invasive needle indentation is a gold standard for the localized determination 
of cartilage thickness, giving more accurate measures than A-mode ultrasound or 





To our knowledge, a direct comparison between histology and needle indentation has also 
not been reported. Other studies have either determined the cartilage thickness by 1 of these 
2 methods (sometimes in comparison to third acoustical or optical procedures) (Hoffmann et 
al. 2010, Pastoureau et al. 2003, Shepherd und Seedhom 1999, Suh et al. 2001), or applied 
other modalities such as high-resolution MRI or laser displacement sensoring (Norman et al. 
1999, Pepin et al. 2009). The discrepancies between needle indentation and histology found 
in the present study are likely due to alcoholic dehydration for histology. However, significant, 
positive correlations between needle indentation and histology or between NIRS-B and 
histology indicate that technically simple, inexpensive, and broadly applicable histology may 
still be valuable for the (comparative) estimation of cartilage thickness in experimental (large) 
animal models and humans. Alternatively, more sophisticated histological techniques only 
available in specialized laboratories, such as undecalcified plastic embedding or the cryostat 
cutting of undecalcified samples (Mika et al. 2011, Buchner et al. 1995) may provide 
information regarding the observed discrepancies. 











The  present  investigation  was  performed  with  normal  sheep  cartilage  in  order  to  first 
establish the system for unaltered, healthy cartilage. It has to be expected that the situation 
in unhealthy cartilage will be different and possibly more complex and will likely require new 
analyses and calibrations (Stumpfe et al. 2013, Tiderius et al. 2007). 
In addition, all data in the present study were obtained with osteochondral plugs extracted 
with a drill from the medial and lateral femur condyle, in order to allow a positioning of needle 
indenter and NIRS fiber probe as close as possible to an exactly perpendicular orientation. 
Future studies  will  have to address the question,  whether  this exact  positioning  of  the 
sensors can be reproduced in vivo on intact condyles under the tightly restricted spatial 
access during minimally invasive surgery (Kopsch et al.). In the current study, measurement 
point 5 of the needle indentation has been used as a reference for the calibration of the NIR 
spectra for cartilage thickness prediction, resulting in robust models with high quality 
parameters and a high accuracy for the prediction of the articular cartilage thickness. In order 
to consider not only the NIRS signal from the central cartilage area directly below the fiber 
probe but also a possible contribution from a wider conus extending to the measurement 
points 1 to 4 of the needle indentation, the average of the measurement points 1 to 5 may be 
used (data not shown). The fact that this approach also yielded high-quality parameters (R2 
between 88.66 and 93.53) and accuracy (RMSECV between 7.93 and 10.5%), can be 
interpreted as a sign of the high stability and reproducibility of the present calibration 
algorithms. 
In the present experimental setup, the application of a specified strain as a percentage of the 
cartilage thickness (as performed in Maenz et al. (Maenz et al. 2016, Maenz et al. 2014)) 
was impossible, since NIRS was executed in undamaged cartilage with unknown thickness 
(i.e., without prior needle indentation). The choice of a defined, fixed 0.1 mm indentation 
depth, aimed at generating highly reproducible and highly accurate experimental conditions 
for all samples and measurements, completely eliminated any influence of creep, since a 
time-dependent motion of the 2 mm diameter fiber probe into the cartilage under constant 
load was impossible. This assumption is further supported by the fact that the force showed 
a rise to a peak, followed by a slow stress-relaxation process until a substantially lower force 
value above 0 N was reached. 
In contrast, it may be very difficult to define an appropriate force suitable to generate such 
reproducible experimental conditions, because of the variable viscosity of the tissue with time 
and  among  different  samples  (due  to,  e.g.,  creep  and  relaxation).  Furthermore,  single 





measurements at full cartilage relaxation may require time periods in the range of hours, with 
the serious risk of substantial cartilage alterations (e.g., progressive water loss or tissue 
break-down).  Finally,  an  unequivocal  determination  of  the  time  point  of  full  cartilage 
relaxation may further complicate or extend the measurements. In our opinion, the choice of 
the indentation depth therefore does not question, but rather strengthens the validity of the 
present results. 
The range of the measurement error in the present study extends from approximately 8% to 
 
10% and thus compares well with the relative measurement errors reported in previous 
studies comparing either needle probe and ultrasonic measurements (range between 8.7% 
and 20.5%, depending on cartilage thickness and indenter radius (Suh et al. 2001)) or needle 
probe and static NIRS measurements (range between 5.5% and 7.1% (Afara et al. 2013a)). 
The accuracy of cartilage prediction in the present study is thus regarded as highly 
satisfactory for  a  non-destructive  technique  potentially  applicable  for  hand-guided  NIRS 





NIRS-B allows the prediction of articular cartilage thickness with a high accuracy (< 0.1 mm) 
and high-quality parameters after development of an optimized data analysis model in 
comparison with the gold standard needle indentation. Prediction of cartilage thickness can 
therefore not only be performed by static NIRS but also by dynamic combined NIRS-B, at 
least at an experimental level. Non-destructive, force-independent NIRS may thus also be 
suitable for intra-operative determination of the cartilage thickness in human disease or 
experimental models. 
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4.3. In vitro analysis of the potential cartilage implant bacterial nanocellulose 
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Biocompatible bacterial nanocellulose (BNC) shows high potential as wound dressing and 
dura mater replacement, and even for the development of blood vessel or cartilage implants. 
Thus, the regenerative capacity of BNC implants was analyzed using a standardized bovine 
cartilage punch model. 
Cartilage rings with an outer diameter of 6 mmand an inner defect diameter of 2 mm were 
derived  from  the  trochlear  groove  (femur-patellar  articulation  site).  BNC  implants  were 
cultured inside the cartilage rings for up to 12 weeks. Cartilage-BNC-constructs were then 
evaluated   by   histology   (hematoxylin/eosin;   safranin   O),   immunohistology   (aggrecan, 
collagens 1 and 2), and for protein content, mRNA expression, and push-out force of the 
implants. 
Cartilage-BNC-constructs displayed vital chondrocytes (≥ 90% until week 9; > 80% until 12 
weeks), preserved matrix integrity during culture, limited loss of matrix-bound proteoglycan 
from ‘host’ cartilage or cartilage-BNC-interface, and constant release of proteoglycans into 
the culture supernatant. 
In addition, the content of the matrix protein collagen 2 in cartilage and cartilage-BNC- 
interface was approximately constant over time (with very limited quantities of collagen 1). 
Interestingly, BNC implants showed: (1) cell colonization of the implant; (2) progressively 
increasing mRNA levels for the proteoglycan aggrecan and collagen 2 (max. fivefold); and 
(3) significantly increasing push-out forces during culture (max. 1.6-fold). 
Retained tissue integrity and progressively increasing chondrogenic differentiation in implant 
and cartilage- implant-interface suggest beginning cartilage regeneration in the BNC in the 
present model and indicate a high potential of BNC as a cartilage replacement material. 
Thus, the present model appears suitable to predict the in vivo performance of cartilage 





Keywords: Bovine cartilage punch model, bacterial nanocellulose, regeneration model, 
articular cartilage, implant push-out force 








Partial- or full-thickness degenerative or traumatic knee cartilage lesions lead to progressive 
cartilage  deterioration  and  finally  to  osteoarthritis.  Established  surgical  approaches  to 
cartilage repair include: (1) autologous chondrocyte implantation (ACI) following chondrocyte 
harvest from healthy cartilage regions; (2) microfracture of the bone plate below the cartilage 
to release mesenchymal stem cells from the bone marrow; and (3) transfer of healthy 
osteochondral plugs into the defect (osteoarticular transfer- OATS/mosaicplasty). These 
procedures are very attractive and show promise for initial cartilage regeneration (Hunziker 
2002, Musumeci et al. 2014). 
 
However, the quality of the repair tissue is still unsatisfactory, with inconsistent and poor 
histology (fibrous instead of hyaline cartilage), decreased mechanical competence, and a 
higher permeability of the repaired tissue in comparison to normal cartilage (Dell'Accio et al. 
2006, Ye et al. 2014). Novel techniques for tissue engineering have recently entered clinical 
practice, e.g., second generation ACI techniques like matrix-assisted chondrocyte 
implantation/transplantation (m-ACI/MACT), which normally aim at reliable and long-term cell 
attachment to the defect area (Bachmann et al. 2004, Dewan et al. 2014, Gobbi et al. 2015, 
Kon et al. 2009). These techniques are based on materials like collagen 1/3 membranes 
(Bartlett W. 2006, Gillogly und Wheeler 2015, Steinwachs und Kreuz 2007), and combine 
several advantages, i.e., a shorter operation time, more limited surgical trauma, and the 
absence of complications due to the use of the outer bone membrane (periosteum; e.g., graft 
overgrowth). 
Because of its unique material properties, bacterial nanocellulose (BNC) is very attractive as 
a novel biomaterial for many potential biomedical applications. Numerous in vitro and in vivo 
publications indicate high biocompatibility and biofunctions of BNC (Ahrem et al. 2014, Avila 
et al. 2015, Avila et al. 2014, Feldmann et al. 2013, Klemm et al. 2001, Kowalska-Ludwicka 
et al. 2013, Lang et al. 2015, Moritz et al. 2014, Napavichayanun et al. 2016, Pretzel et al. 
2013, Saska et al. 2017, Wippermann et al. 2009b, Schumann et al. 2009, Bodin et al. 2007). 
BNC may be preferable over collagen implants because collagens are regularly derived from 
natural sources, in particular animal tissues, and thus the removal or inactivation of viral 
contamination remains an ever-increasing challenge for the safety of biomedical products 
and complete risk elimination has not been achieved (Mark Plavsic; http:// 
www.biopharminternational.com/integrated-approachensure-viral-safety-biotherapeutics-0). 
In contrast, the successful removal or inactivation of bacteria or bacterial products (in 
particular lipopolysaccharides) during the production of BNC products intended for clinical 
use is well established and documented (company information, Jenpolymer Materials UG & 
C. KG, Jena; Germany). 





In particular, a high potential of BNC as a matrix for cartilage implants has been suggested 
on the basis of its favorable mechanical properties, its significant support of chondrocyte 
proliferation/ingrowth, and the lack of significant activation of pro-inflammatory reactions 
(Horbert et al. 2018, Svensson et al. 2005, Moller et al. 2017,). However, there are currently 
no in vitro studies characterizing the precise cellular and molecular mechanisms underlying 
cartilage regeneration in the BNC implant. The present study was thus performed to 
investigate the in vitro performance of BNC implants and to assess whether the results mirror 
their in vivo performance as a cartilage replacement material. The following questions were 
addressed: (1) is the in vitro model suitable for the pre-testing of cartilage replacement 
materials intended for future clinical application; and (2) does the model allow a 
comprehensive description of the mechanisms underlying in vitro cartilage regeneration. A 
cartilage implant model was thus applied using: (1) ‘host’ cartilage cylinders derived from the 
bovine femoral trochlea using a standardized punch system; and (2) inserted BNC implants 
(Horbert et al. 2018). The cartilage-BNC-constructs were kept in culture for up to 12 weeks, 
and then analyzed by: (1) (immuno-) histological staining; (2) protein assays in tissue and 
supernatants; (3) transcriptional analysis; and (4) evaluation of the implant push-out force. 
‘Host’ cartilage and BNC implants remained vital with intact matrix and only slight loss of 
matrix-bound proteoglycan throughout 12 week in vitro culture. The BNC implants supported 





Biosynthesis of BNC implants 
 
 
A nutrient medium according to Schramm and Hestrin (Schramm und Hestrin 1954b) was 
applied for the cultivation of Gluconacetobacter xylinus (DSM 14666; synonym 
Komagataeibacter  xylinus,  Deutsche  Sammlung  für  Mikroorganismen  und  Zellkulturen 
GmbH, Braunschweig, Germany). The medium was inoculated with a pre-culture of the 
bacteria in a volume ratio of 20:1 and cultivated in 150 ml-beakers containing 64 glass tubes 
(inner diameter of 2.4 mm; 30 ml of inoculum per beaker) for 14 days at 28°C. The size of the 
BNC implants inside the tubes was 2.3 mm in diameter and 3 to 7 mm in height. 
To remove bacterial and media remnants, the BNC was treated with 0.1 M aqueous sodium 
hydroxide solution at 100°C 10 min, rinsed several times with pyrogen-free water, steam 
pressure sterilized and stored until further use (room temperature). 





Preparation and culture of bovine cartilage rings with BNC implants 
 
 
Bovine cartilage was resected from the knees of German Holstein Friesian Cattle (age of 24 
months). Cartilage rings were prepared from the lateral aspects of the facies articularis of the 
femur-patellar articulation site as previously published (Horbert et al. 2018, Pretzel et al. 
2013) and an inner defect (diameter 2 mm) was generated using biopsy punches. BNC 
implants (Polymet Jena e.V., Jena; Germany) were placed into the central defect of the ‘host’ 
cartilage rings and kept in culture for 0, 4, 8, 10, and 12 weeks (Fig. 22; (Horbert et al. 
2018)). Thereafter, cartilage-implant constructs were analyzed by histology. In addition, gene 
expression in chondrocytes derived from ‘host’ cartilage, its surface, or BNC implants was 
investigated (for preparation see below). The quantity of cartilage matrix proteins released 
into the culture supernatant, and the remaining content in ‘host’ cartilage and the 




Figure 22: Schematic depiction of the in vitro model. First, hot liquid agarose (2%) was added into 
the wells of a 48-well plate (A). Cylindrical pockets with a defined size of 6 mm were generated by 
insertion of a metal-pin plate into the hot agarose and removal following gelation of the agarose (B, C). 
The BMC implant was inserted into the inner defect of the cartilage rings using forceps (C1) and, after 
embedding of the resulting constructs into the agarose (D), the well was filled with culture medium (E). 
Cartilage-implant constructs were histologically characterized after in vitro culture. Also, the mRNA 
expression in chondrocytes isolated from ‘host’ cartilage, the cells on its surface, and the BNC implant 
was investigated (F). Finally, the amount of cartilage proteins in supernatant, ‘host’ cartilage rings and 
the cells located on its surface was analyzed. 





A total of 120 cartilage rings each were obtained from bovine knee joints (n = 7 animals) and 
analyzed by histology (n = 4), biochemistry (n = 10; n = 5 each for RT-PCR and protein 
determination), and biomechanics (n = 10; 24 samples for each time point). Culture 







Viability was assessed using fluorescein diacetate/ propidium iodide live/dead staining 
(Kunisch et al. 2017; Horbert et al. 2018). Four images each were taken in 3 chambers of the 
culture slides using a fluorescence microscope Axiovert200 M, an Axio- Cam MRm camera, 
and the AxioVision Rel4.8 program (all Zeiss, Oberkochen, Germany). Viable and dead cells 
were counted in all images using the cellprofiler software (www.cellprofiler.org) (Carpenter et 
al. 2006) and viability was expressed as the mean percentage of viable cells. 
 
 
Histology and immunohistology 
 
 
Cartilage-BNC-constructs, either non-cultured or cultured for 4, 8, 10 or 12 weeks, were fixed 
in PBS with 4% paraformaldehyde and embedded in paraffin. The samples were cut into 6 
µm sections and stained with hematoxylin/eosin (HE) or safranin O (to assess the 
proteoglycan content). 
Immunohistology for aggrecan, collagen 1, and collagen 2 was performed as previously 
reported (Horbert et al. 2018). 
All immunohistological stainings using isotype-matched control antibodies with irrelevant 
specificity were negative. 
 
Score for cell migration 
 
 
Colonization of the BNC implants was analyzed using a published score (Pretzel et al. 2013, 
Horbert et al. 2018), consisting of 4 levels (0 = implant without cells, 1 = single adherent 
cells, 2 = several adherent cells, 3 = cell-layer on the implant). Scoring was independently 
performed by three individual observers, expressing the results as the mean ± standard error 
of the individual scores. 
 
Scores for safranin O, collagen 1, collagen 2 and aggrecan 
 
 
The intensity of the safranin O staining or the immunostaining for aggrecan, collagen 2, and 
collagen 1 was quantified using a published semi-quantitative score (Pretzel et al. 2013, 
Horbert et al. 2018), consisting of 4 levels (0 = no staining; 1 = weak staining; 2 = moderate 





staining; 3 = strong staining). The sections were independently scored by three individual 
observers, expressing the results as the means ± standard error of the individual values. 
 
Scanning electron microscopy 
 
The micro-and nanostructure of the BNC samples and the morphology of the chondrocytes 
migrated onto the surface of the BNC were investigated by scanning electron microscopy 
(SEM). The samples were fixed in 2% (v/v) glutaraldehyde in 0.2 M sodium cacodylate buffer 
(pH 7.2). After 72 h, the samples were rinsed twice in 0.2 M sodium cacodylate buffer and 
dehydrated in ascending ethanol series [50, 60, 70, 80, 90, 100% (v/v)]. Prior to critical point 
drying  (EMITECH  K850;  Emitech,  Ashford,  UK),  the  ethanol  was  exchanged  against 
acetone. Dried samples were mounted with carbon tabs on aluminum stubs, sputter-coated 
(EMITECH K500; Emitech, Ashford, UK), and analyzed (beam energy of  10 kV; XL-30 
ESEM; Philips, Hamburg, Germany). 
 
 
Quantitative real-time polymerase chain reaction (qRT-PCR) 
 
 
To quantify the mRNA expression of aggrecan, collagen 2, and collagen 1, RNA was 
separately isolated from: (1) cells in the ‘host’ cartilage; (2) cells located on its surface (see 
below); and (3) cells in BNC implants (Fig. 22F). For RNA isolation from the different groups, 
the BNC implants were removed from the cartilage rings. Ten implants were pooled and kept 
in a tube with 300 µl lysis buffer at - 80°C for subsequent RNA isolation. 
Empty cartilage rings were treated for 1 minute in tubes with 300 µl lysis buffer each under 
continuous rotation to obtain the RNA from the cells located on the cartilage surface (Horbert 
et al. 2018). The rings were then removed from the tubes, followed by separate storage of 
the two components at - 80°C. 
Cartilage rings were cut with scissors in 800 µl TriZol (Life Technologies, Carlsbad, CA, 
USA), incubated for 15 minutes at RT, and centrifuged for 3 minutes at 12.000 rpm (Horbert 
et al. 2018). Total RNA from the cartilage rings, the lysed cells on the cartilage surface, or 
the BNC implants was isolated using the Quiagen Kit (RNeasy® mini kit; Qiagen, Hilden, 
Germany; including DNase digestion). 
qRT-PCR  (i-cycler  PCR  system;  BioRad,  Munich,  Germany)  for  the  quantification  of 
aggrecan, collagens 1 and 2, and the housekeeping gene aldolase was done as previously 
published (Horbert et al. 2018; Table 1). Gene expression was normalized to the relative 
expression of aldolase. 








To quantify aggrecan, collagen 2, and collagen 1, protein was extracted from: (1) 
chondrocytes located in the ‘host’ cartilage matrix; and (2) chondrocytes located on its 
surface. For this purpose, the BNC implants were removed from the cartilage rings. Protein 
from (1) was isolated by cutting in 1000 µl of 4 M GuHCL with scissors and incubation at 4°C 
for 48 h under rotation. Protein from (2) was isolated using acetone precipitation according to 
the instructions of the RNeasy® mini kit supplier (Qiagen). 
 
Quantification of glycosaminoglycans 
 
 
The release of glycosaminoglycans from the cartilage-BNC-constructs into the supernatant, 
and the remaining content in ‘host’ cartilage and the cells located on its surface, was 
measured using the DMB assay (Chandrasekhar et al. 1987, Farndale et al. 1986, Horbert et 
al. 2018). The supernatants of the respective week and group were pooled for the analysis. 
 
Enzyme-linked immunosorbent assay (ELISA) 
 
 
The concentrations of aggrecan, collagen 2, and collagen 1 in the culture supernatant, and 
the remaining content in ´host´ cartilage and the cells located on its surface, were quantified 
utilizing ELISA-Kits as previously described (Horbert et al. 2018). The supernatants of the 






Biomechanical testing of samples from the different time points and test series (10 samples 
each) was executed using a static universal test system (Zwicki 1120®, Zwick/Roell, Ulm, 
Germany) at the Department of Orthopedics and Sportsorthopedics, Technische Universität 
München as previously described (Horbert et al. 2018). In brief, the push-out force of the 
implant from the ‘host’ cartilage ring (Fmax(insert)) was measured applying a cylindrical indenter 
with a diameter of 1.8 mm (0.2 mm less than the central defect diameter). To account for 
remaining friction forces between indenter and empty ‘host’ cartilage ring, the test was 
repeated once more and the resulting force (Fmax(empty)) was then subtracted [Fmax(insert) - 
Fmax(empty)= ∆Fmax(res)]. Values were given in N and, or comparison with previous publications, 
in kPa (after division by the lateral surface of the BNC cylinder (0.8163 mm2). 








Results were displayed as means ± standard error of the mean. The Mann-Whitney U test 
was used for statistical analysis and the statistical software SPSS 22.0 was applied. 








The BNC insert maintained lateral contact to the defect walls throughout culture (Fig. 23A). 
Resident cartilage cells were vital without signs of alterations and showed positive nuclear 
staining despite the relatively long culture periods (up to 12 weeks), suggesting well suitable 
culture conditions (Fig. 23A). SEM confirmed the superficial seeding of the BNC implants 
with numerous cells with spread-out morphology and an underlying, dense extracellular 
matrix (Figs. 23B1, 24; time point 8 weeks). The matrix of the cartilage appeared largely 
intact  over  time  (Fig.  23A).  However,  cartilage  close  to  the  defect  edge  contained 
proliferation-induced cell clusters, possibly as a consequence of the initial tissue injury by the 
biopsy punch (Fig. 23A; see hash). 
 
A generally high viability of the chondrocytes in the cartilage rings was confirmed by 
fluorescein diacetate/propidium iodide live-dead staining of chondrocytes enzymatically 
isolated from the cartilage at weekly intervals, resulting in viability rates of close to or [90% 
until week 9, and[80% for the remaining time points (Fig. 24). 







Figure 23: HE staining of the cartilage-BNC-constructs after culture in the central cartilage 
defect for 0, 4, 8, 10, or 12 weeks. (A) Morphology of  the cells in cartilage, BNC implant and at the 
cartilage-implant interface; # = proliferation induced cell clustering; * = migration of chondrocytes onto 
the BNC implant. (B) Scanning electron microscopy images of the cells migrated onto the BNC 
surface; magnification top panel: x 100 (B1); left bottom panel: x 1000 (B2); right bottom panel: x 2000 
(B3). (C) Semiquantitative analysis of cell colonization of the BNC implants; migration score: 0 = 
implant without cells, 1 = single adherent cells, 2 = several adherent cells, 3 = cell-layer on implant; * p 
B 0.05 versus 0 weeks. 
 
 
Cartilage-BNC-constructs showed the earliest substantial colonization of the initially cell-free 
BNC implants after 4 weeks (Figs. 23A, C; see asterisks). Cell colonization significantly 
increased from 0 weeks to all subsequent time points (Fig. 23C). 








Figure 24: Viability of the chondrocytes in the cartilage ring throughout culture. Chondrocytes 
were enzymatically isolated from the cartilage at weekly intervals and cultivated for 1 day. Viability was 
assessed using fluorescein diacetate/propidium iodide staining. Data are expressed as mean ± 
standard error of the mean (SEM) 
 
Content of proteoglycans, aggrecan, collagen 2, and collagen 1 
 
 
The data suggesting a retained matrix integrity in the surrounding cartilage were further 
supported by a limited, non-significant decrease of the safranin O staining during culture 
(from a semi-quantitative score of 2.2 for freshly isolated cartilage to a score of 1.3 after 12 
weeks of culture; Figs. 25, 26A); this indicated an only limited loss of proteoglycans during 
this time period. 








Figure 25: Safranin O, aggrecan, collagen 2, and collagen 1 (immuno)staining of the BNC 
 
implants after placement into the inner defect of the cartilage rings and subsequent culture for 
 
0, 4, 8, 10, or 12 weeks. 
 
 
Also the cartilage-implant interface showed no significant decrease of the safranin O staining 
 
(from 2.2 to 1.2; Figs. 25, 26A). 
 
In contrast, in the implant there was no safranin-O staining at any time point. 































Figure 26: Semiquantitative analysis of Safranin O, aggrecan, collagen 2, and collagen 1 
(immuno)staining in ‘host’ cartilage, interface, and BNC implants. Degree of staining: 0 = no 
staining, 1 = weak staining, 2 = moderate staining, 3 = strong staining; values are shown as means ± 
standard error (SEM) of the mean; * p ≤ 0.05 versus 0 weeks; # p ≤ 0.05 versus 4 weeks. 
 
 
For the aggrecan staining, a significant increase was noted in the surrounding cartilage 
throughout culture (p ≤ 0.05 for 4, 8, 10, and 12 weeks versus 0 weeks; Figs. 25, 26B). The 
aggrecan immunostaining in cartilage-implant-interface and implant during 12 week culture 
was largely constant (scores between 0.9 and 1.5 for the interface and between 0.4 and 0.9 
for the implant, with a significant intermediate peak at 8 weeks for the implant; Figs. 25, 26B) 
Also for collagen 2 the immunostaining was largely constant during 12 week culture in 
cartilage ring (scores between 1.3 and 1.7), cartilage-implant-interface (between 1.3 and 
1.7), and BNC implant (between 2.0 and 2.4), without any significant differences among the 
individual time points (Figs. 25, 26C). 
There was very little  collagen 1 immunostaining (scores mostly between 0 and 1.0) in 
cartilage ring, interface, and implant. There were again no significant differences among the 
different time points (Figs. 25, 26D). 





Proteoglycan content of tissue extracts and culture supernatant (DMB-assay) 
 
 
Confirming the results of safranin O and aggrecan staining, the decline of the 
glycosaminoglycan (GAG) content in the cartilage ring throughout culture (from 5080 µg/ml 
for the freshly isolated cartilage to 3454 µg/ml at 12 weeks; Fig. 27) was limited and not 
significant. 
The GAG content in chondrocytes migrated onto the surface was approx. sevenfold lower 
and showed a numerical decline throughout culture (from 706 µg/ml in fresh cartilage to 383 
µg/ml at 12 weeks; Fig. 27A). 
 
Also in the culture supernatant a very limited, nonsignificant decrease of the GAG content 
was observed throughout culture (from 118 µg/ml at 4 weeks to 113 µg/ml at 12 weeks; Fig. 
27A), as confirmed by the constant release of aggrecan into the supernatant (ELISA; from 6 






Figure 27: Quantitative analysis of proteoglycan content or release (DMB assay) or newly 
synthesized collagen 2 and aggrecan (ELISA) in cartilage-BNC-constructs. Proteoglycans (DMB 
assay) and newly synthesized collagen 2 and aggrecan (ELISA) were quantified in fresh and cultured 
‘host’ cartilage (cartilage), cells located on its surface (cartilage surface), and culture supernatant 
(supernatant), when using BNC implants (A for proteoglycan; B for collagen 2 and aggrecan); values 
are expressed as mean ± SEM 
 
Collagen 2 and 1 content of culture supernatant (ELISA) 
 
 
The decline of the collagen 2 release (from 562 ng/ml at 4 weeks to 189 ng/ml at 12 weeks 
Fig. 26B), and the increase of the collagen 1 release during culture (from 165 ng/ml at 4 











Gene expression for aggrecan, collagen 2, and collagen 1 (RT-PCR) 
 
 
Aggrecan expression in the ´host´ cartilage significantly decreased over time (p ≤ 0.05 for 4 
and 10 weeks versus 0 weeks), whereas the cartilage surface cells did not significantly 
change.  Interestingly,  the  implant  showed  a  transient,  substantial  peak  of  aggrecan 











































































Figure 28: qRT-PCR analysis for aggrecan, collagen 2, and collagen 1 gene expression in ‘host’ 
cartilage, cartilage surface, and BNC implants. mRNA expression for aggrecan (A), collagen 2 (B), 
collagen 1 (C), aggrecan/collagen 1 ratio (D), and collagen 2/collagen 1 ratio (E) A-E was analyzed 
prior to and after 4, 8, 10, and 12 weeks of tissue culture; relative gene expression of the cells located 
in the ‘host’ cartilage (cartilage), on its surface (cartilage surface), and on/in the BNC implant (implant); 
values are expressed as means ± SEM; * p ≤ 0.05 versus 0 weeks; # p ≤ 0.05 versus 4 weeks. 





Collagen 2 expression in ‘host’ cartilage and cartilage surface cells showed a significant 
decrease over time (cartilage ring: p ≤ 0.05 for 4, 8, 10 and 12 weeks versus 0 weeks; 
surface cells:  p ≤ 0.05 for 12 weeks versus 0 weeks), whereas the collagen 2 expression in 
the implant increased from baseline to a transient twofold peak at 8 weeks and thereafter 
declined again (Fig. 28B). 
Expression of collagen 1 in the ‘host’ cartilage significantly increased over time (p ≤ 0.05 for 
 
8 weeks versus 4 weeks), whereas the collagen 1 expression in cartilage surface cells and 
implant only increased to transient peaks at 4 (sixfold) and 8 weeks (twofold), respectively, 
with a decrease thereafter (Fig. 28C). 
Whereas the aggrecan/collagen 1 ratio in the ´host´ cartilage displayed a minor increase at 
 
12 weeks (after a significant decrease at 8 and 10 weeks versus 0 weeks) and the 
aggrecan/collagen 1 ratio in the cartilage surface cells showed a long-term rise (Fig. 28D), 
the aggrecan/collagen 1 ratio in the implant increased to an intermediate peak (8 weeks; 14- 
fold), with a subsequent decrease (Fig. 28D). 
In contrast to the aggrecan/collagen 1 ratio, the collagen 2/collagen 1 ratio in the ´host´ 
cartilage significantly decreased over time (p ≤ 0.05 for 4, 8 and 10 weeks versus 0 weeks; 
Fig. 28D). However, this ratio long-lastingly increased in cartilage surface cells (fivefold peak 
at 12 weeks) and implant (sevenfold peak at 8 weeks; Fig. 28E). 
 
Push-out forces of the cultivated cartilage-BNC-constructs (biomechanical testing) 
 
Notably, the push-out force for the BNC implants significantly increased during culture (from 
 
0.05 ± 0.01 N or 59.09 ± 6.56 kPa at 0 weeks to 0.08 ± 0.01 N or 97.08 ± 17.26 kPa at 12 




Figure 29: Push-out tests of the cartilage-BNC-constructs. Values are expressed as mean ± SEM; 
 
* p ≤ 0.05 versus 0 weeks. 








The aim of the current study was to assess the long-term in vitro performance of a bacterial 
nanocellulose (BNC) implant using a standardized bovine cartilage punch model. The central 
results were that: (1) cartilage-BNC-constructs showed vital chondrocytes, preserved matrix 
integrity, limited loss of proteoglycan from the matrix of ‘host’ cartilage ring or cartilage-BNC- 
interface, and a constant release of proteoglycans into the culture supernatant; (2) BNC 
implants  showed  cell  immigration/colonization  and  increased  aggrecan  and  collagen  2 
mRNA levels; and (3) BNC implants displayed significantly elevated push-out forces from the 
‘host’  cartilage  over  time.  The  results  of  this  study  concord  well  with  the  known 
biocompatibility of BNC implants for medical applications (Ahrem et al. 2014, Avila et al. 
2015,  Avila et  al.  2014,  Bodin et  al.  2007,  Feldmann et  al.  2013,  Klemm  et  al.  2001, 
Kowalska-Ludwicka et al. 2013, Lang et al. 2015, Markstedt et al. 2015, Moritz et al. 2014, 
Napavichayanun et al. 2016, Saska et al. 2017, Schumann et al. 2009, Wippermann et al. 
2009a) and their potential as a cartilage replacement material. BNC hydrogels may thus be 
well suitable for in vivo cartilage repair by matrix-associated chondrocyte transplantation. In 
addition, the lack  of  in vivo biodegradability may render BNC a sustainable scaffold to 
support cell ingrowth and subsequent remodeling of the joint cartilage. 
The present long-term in vitro cartilage regeneration model, based on reproducible, easily 
available, and ethically unproblematic tissue supply, appears well suited for the evaluation of 
chondral implants with proven or expected clinical potential (Horbert et al. 2018) and 
references therein). The ´host´ cartilage ring shows only minor cartilage degeneration, and 
zones  at  the  defect  edge  containing  proliferation-induced  cell  clusters  may  indicate  an 
attempt at the repair of damaged cartilage and the seeding of the cartilage implant (Lotz et 
al. 2010, Morales 2007). 
On one hand, the ‘host’ cartilage ring demonstrated long-term stability over time as shown 
by: (1) limited indications of cartilage degeneration and chondrocyte viability rates of [90% for 
9 weeks of culture; (2) limited proteoglycan loss and significant increase of aggrecan content, 
as well as stable collagen 2 content (small amounts of collagen 1), in good agreement with 
published own data on a co-culture system with a collagen type I hydrogel (Horbert et al. 
2018). On the other hand, there were some signs of a limited dedifferentiation of the resident 
chondrocytes particularly at later time points, as shown by significantly decreasing aggrecan 
and collagen 2 mRNA levels and the resulting collagen 2/collagen 1 and aggrecan/collagen 1 
ratios. This demonstrates that the current model in principle supports long-term culture in 
vitro with at least partial transferability to the in vivo situation, but may become more 
vulnerable to in vitro artifacts at 10 and 12 weeks. 





The BNC implants showed a progressive colonization, paralleled by signs of chondrocyte 
emigration particularly from the surface of the ‘host’ cartilage. This underlines the high cyto- 
compatibility of the BNC implant in the current in vitro model, as previously shown in 
experimental (Ahrem et al. 2014, Bodin et al. 2007, Feldmann et al. 2013, Moritz et al. 2014, 
Nimeskern et al. 2013, Pretzel et al. 2013, Saska et al. 2017) and in vivo studies (Avila et al. 
2015, Avila et al. 2014, Klemm et al. 2001, Kowalska-Ludwicka et al. 2013, Lang et al. 2015, 
Napavichayanun et al. 2016, Schumann et al. 2009, Wippermann et al. 2009a). 
As a sign of beginning cartilage regeneration, the initially cell-free BNC implants showed 
deposition of the matrix proteins collagen 2 and aggrecan throughout culture. This was 
further stressed by progressively rising levels of collagen 2 and aggrecan mRNA. The locally 
synthesized, cartilage-specific matrix proteins seemed to be successfully retained in the BNC 
implants, as shown by a constant aggrecan release and a decreased collagen 2 release into 
the culture supernatant over time. 
There were no clear indications for chondrocyte dedifferentiation in BNC implants over time, 
since: (1) the content of the cartilage-specific proteins aggrecan and collagen 2 (and of the 
connective tissue collagen 1) was stable throughout culture; and (2) the aggrecan/ collagen 1 
and collagen 2/collagen 1 mRNA ratios were substantially increased over 8 weeks of tissue 
culture (up to 14- and 6-fold, respectively). The current regeneration model may thus support 
a middle- term phenotypic stability of the chondrocytes colonizing the implant, in line with 
previous publications describing similar models (Horbert et al. 2018) and references therein). 
In addition, the current cellular and molecular data on cartilage regeneration and chondrocyte 
colonization/differentiation further underline the potential of BNC for cartilage repair. 
The BNC implants developed significantly augmented push-out forces from ‘host’ cartilage 
throughout culture. Thus, high cell vitality, considerable cell colonization, and prolonged local 
matrix production apparently result in increased lateral attachment between implant and 
surrounding cartilage ring. The augmentation of the push-out forces of the initially cell-free 
BNC implants during the 12-week culture [from 59.09 to 97.08 kPa, i.e., by approx. 64%] 
generated final values well comparable to those previously published for PGA-constructs 
after 5 weeks (Hunter und Levenston 2004) or for cellseeded agarose hydrogels after 6 
weeks of culture (Vinardell et al. 2009). The underlying mechanisms may include: (1) the 
tissue formed at the cartilage implant interface [(Moretti et al. 2005); compared with Figs. 
23B1, 24]; (2) sprouting of different components of ECM in the interfacial region (compare 
with separate manuscript on three-dimensonally perforated BNC in this issue; Horbert et al. 
2018) and (3) the local absence or presence of cell death   (Theodoropoulos et al. 2011, 
Horbert et al. 2018) and references therein.   Highly standardized experimental conditions 
were applied in the present study, including preparation of BNC implants and ‘host’ cartilage 





rings, placement and culture of the implants inside the cartilage, careful harvesting and 
overnight transport of 10 fresh, unfrozen cartilage-BNC-constructs for each time point to the 
Department of Orthopedics and Sportsorthopedics, Technische Universität München, and 
immediate final biomechanical testing. These standardized procedures make an influence of 
a differential bulk growth of the BNC implant at the different culture time points on the 
resulting push-out forces very unlikely. This again shows that BNC implants may serve as a 
suitable scaffold material in general (Avila et al. 2015, Bodin et al. 2007, Klemm et al. 2001, 
Kowalska-Ludwicka et al. 2013, Lang et al. 2015, Moritz et al. 2014, Napavichayanun et al. 
2016, Saska et al. 2017, Schumann et al. 2009, Wippermann et al. 2009a) and, in particular, 





Largely retained tissue integrity, limited proteoglycan release, and generally high viability of 
local chondrocytes in the ‘host’ cartilage ring (> 90% until 9 weeks), as well as long-term 
stabilization of the chondrogenic phenotype and significantly augmented push-out forces of 
the BNC implant (up to 12 weeks) indicate beginning cartilage regeneration of the BNC 
implant in the current model system. Thus, the present in vitro cartilage repair model seems 
to be suitable to predict the in vivo performance of cartilage replacement materials such as 
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5.  Gesamtdiskussion 
 
 
Ziel der vorliegenden in vitro Studien war es, die Knorpelregeneration von verschiedenen z. 
T. bereits im klinischen Einsatz befindlichen Konstrukten in einem in der Arbeitsgruppe 
Experimentelle Rheumatologie des Uniklinikums Jena etablierten in vitro Systems zu testen. 
Das  vorliegende  Modellsystem  basiert  auf  bovinen  Knorpelzylindern,  in  die  die 
verschiedenen regenerativen Materialien eingebracht werden und bis zu 12 Wochen in vitro 
kultiviert werden können. Nach verschiedenen Zeitpunkten (0, 4, 8 10 und 12 Wochen) 
erfolgte die biomechanische (push-out Versuche), molekularbiologische (qRT-PCR und 
Proteinanalyse) und histologische (semiquantitativer Score) Untersuchung der Konstrukte. 
Ein Vorteil des  auf  bovinen Knorpelstanzen basierenden in vitro Modells ist  neben der 
ethisch unproblematischen Probengewinnung die hohe Reproduzierbarkeit des Systems. 
Der Knorpelring, der das zu untersuchende Implantat umgibt, zeigt nur an den Schnittkanten 
eine geringe Knorpeldegeneration. Die dort zu erkennenden Chondrozyten-Cluster könnten 
darauf  hinweisen,  dass  die  Chondrozyten  versuchen,  den  beschädigten  Knorpel  zu 
reparieren und das Implantat zu besiedeln und mit Matrix zu füllen. Bei allen untersuchten 
Konstrukten wurde neben der vitalen Morphologie der Chondrozyten sowie der intakten 
Matrix-Integrität auch ein leidglich geringer Proteoglykan-Verlust sowie eine verminderte 
Proteoglykan-Freisetzung im Überstand beobachtet. Weiterhin wurde bei allen untersuchten 
Konstrukten eine gute bis sehr gute Zellmigration / Zellkolonisation beobachtet. Das hier 
verwendete in vitro Modell scheint daher für die Testung von chondralen Knorpelimplantaten 
(sowohl innovativen, als auch klinisch etablierten Implantaten) gut geeignet zu sein. Es bietet 
die Möglichkeit, die bei der Knorpelregeneration stattfindenden molekularen Prozesse zu 
entschlüsseln und so zusammen mit den biomechanischen und histologischen Daten 
Vorhersagen für die in vivo „Performance“ von klinisch etablierten und neu entwickelten TE 
Konstrukten zu treffen. 
 
Dieses in vitro Modell scheint allerdings nur begrenzt für die Testung von resorbierbaren 
Materialien wie Bioseed®-C in Frage zu kommen. Eine auf diesem in vitro Modell basierende 
Vorhersage der in vivo Performance scheint aufgrund der schnellen Resorbierbarkeit des 
PGA-Vlieses (42 Tage) nicht möglich. Für solche Materialien müsste das vorliegende in vitro 
System eventuell so modifiziert werden, dass der subchondrale Knochen mit in das System 
einbezogen wird und in einem Knorpel-Knochenzylinder ein zentraler Defekt bis zur 
subchondralen Lamelle generiert wird. In diesen Defekt können dann beispielsweise 
resorbierbare Materialien eingebracht und kultiviert werden. Die vollständige Entfernung der 
Knorpelschicht ohne Schädigung der subchondralen Lamelle ist jedoch technisch sehr 







Parallel zu den in vitro Versuchen wurde das Knorpelersatzmaterial BioSeed®-C der Firma 
 
TTT  in  vivo  untersucht.  Die  entstandenen  Gewebsregenerate  wurden  nach  6  und  12 
 
Monaten molekularbiologisch (qRT-PCR und Proteinanalyse) und histologisch (O´Driscoll 
Scores, modifizierte O´Driscoll Scores und Penada Score) untersucht. Histologisch konnte 
eine Abnahme des Proteoglykan-Gehaltes beobachtet werden. Molekularbiologisch (qRT- 
PCR) zeigte sich, dass die mit dem Implantat BioSeed-C besetzten Defekte eine verminderte 
Expression von Kollagen 1 und eine langfristig erhöht Expression des Knorpelmarkers 
Kollagen 2 aufwiesen. Weiterhin zeigte die PG-Konzentration im Knorpelgewebe (DMB- 
Assay) eine numerische Abnahme des GAG-Gehaltes nach 6 und 12 Monaten im Vergleich 
zum Nullpunkt. Die molekularbiologischen Ergebnisse unterstreichen dabei das 
therapeutische  Potenzial  der  verwendeten  Implantate.  Allerdings  zeigen  die  Ergebnisse 
auch, dass es durch die versetzte Operation beider Kniegelenke zu einer erhöhten Belastung 
des Knorpels bzw. zu einer Schädigung des umliegenden Knorpels im Kniegelenk kommt. 
Mit diesen Daten wird momentan eine Veröffentlichung vorbereitet. 
 
Neben den in vitro und in vivo Versuchen mit den verschiedenen Knorpelersatzmaterialien 
wurde auch die Knorpeldickenvorhersage unter dem Einfluss variierender Belastung mittels 
Nahinfrarot-Spektroskopie (NIRS-B) ex vivo untersucht. Mit dem NIRS Messsystem war es 
möglich, die Knorpeldicke im Knie des Großtiermodells Schaf zerstörungsfrei optisch zu 
detektieren. Die mittels NIRS-B gewonnenen Daten wurden dabei mit den Ergebnissen der 
mittels der Goldstandard-Methoden Nadelindentation bzw. Histologie erhobenen Daten 
verglichen  und  für  die  Entwicklung  geeigneter  Kalibrierungsalgorithmen  verwendet.  Mit 
diesen  Algorithmen  war  dabei  eine  sehr  genaue  Knorpeldickenvorhersage  (<0,1  mm) 
möglich. Mit diesem Messsystem scheint es also möglich zu sein, eine nichtinvasive 
Beurteilung der Knorpeldicke und der Knorpeleigenschaften von gesundem bzw. 
regeneriertem Knorpel realisierbar durchzuführen. 
 
Es gibt allerdings einige Limitationen, auf die bei späteren Untersuchungen eingegangen 
werden sollte. Zum einen wurde für die Messungen in der vorliegenden Studie normaler 
Schafsknorpel verwendet, um das NIRS-B Messsystem zunächst für unveränderten und 
gesunden Knorpel zu etablieren. Allerdings könnte die Situation bei degeneriertem Knorpel 
anders und möglicherweise komplexer sein und somit neue Analysen und Kalibrierungen 
erfordern. Eine weitere Einschränkung ist, dass die gewonnenen Daten eine möglichst 
senkrechte Ausrichtung an den Knorpel-Knochen Zylindern aus der Hauptbelastungszone 
der medialen und lateralen Femurkondyle erfordern. Diese exakte Positionierung der 
Messsonde an intakten Kondylen muss bei einem räumlich eng begrenzten Zugang im 
Rahmen einer minimal-invasiven Operation noch reproduziert werden. 
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6.  Schlussfolgerung 
 
Die vorliegende Arbeit sollte verschiedene z. T. etablierte klinische Knorpelersatzmaterialien 
in vitro und in vivo untersuchen. Die gewonnen Ergebnisse sollten anschließend in die 
Entwicklung von standardisierten Verfahren für die Prüfung von TE Konstrukten für den 
orthopädisch-unfallchirurgischen Einsatz einfließen. 
 
Unter Berücksichtigung aller Ergebnisse lassen sich folgende Schlussfolgerungen ziehen: 
 
- Das hier verwendete in vitro Modell bietet sehr gute Versuchsbedingungen für die 
Kultivierung von innovativen TE Konstrukten oder klinisch etablierten 
Knorpelersatzmaterialien über einen Zeitraum von bis zu 12 Wochen. Die 
verschiedenen biomechanischen, molekularbiologischen und histologischen 
Untersuchungen ermöglichen es einerseits, die bei der Knorpelregeneration 
stattfindenden molekularen Prozesse zu entschlüsseln und andererseits das 
Einwachsen des Knorpelersatzmaterials in das umliegende Gewebe zu beurteilen 
(push-out-Versuche),   um  so  Vorhersagen  für  die  in   vivo  „Performance“  der 
Konstrukte zu treffen. 
- Dieses  in  vitro  Modell  scheint  allerdings  nur  begrenzt  für  die  Testung  von 
resorbierbaren Materialien wie Bioseed®-C in Frage zu kommen. Eine auf diesem in 
vitro Modell basierende Vorhersage der in vivo Performance scheint aufgrund der 
schnellen Resorbierbarkeit des PGA-Vlieses (42 Tage) nicht möglich. Für 
resorbierbare Materialien müsste das vorliegende in vitro System so modifiziert 
werden, dass ein zentraler Knorpeldefekt in einem zuvor entnommenen Knorpel- 
Knochen Zylinder generiert und anschließend bis zu 12 Wochen kultiviert wird. Die 
vollständige Entfernung der Knorpelschicht ohne Schädigung der subchondralen 
Lamelle ist dabei jedoch technisch sehr anspruchsvoll. 
- Die Auswertung der in vivo Proben zeigte trotz klarer klinischer Erfolge mit BioSeed-C 
im Schafmodell noch keine eindeutige Ausbildung von vollwertigem Knorpelgewebe. 
Zum Teil sind jedoch klare Unterschiede zwischen den Verumdefekten und den 
Leerdefekten mit einer potenziell prädiktiven Aussage für die in vivo Einheilung zu 
erkennen (eigene Daten). 
- Mit dem NIRS-B Messsystem ist es möglich, optisch nicht erkennbare Unterschiede 
der Knorpeleigenschaften im Knie des Großtiermodells Schaf zerstörungsfrei zu 
detektieren. In einem weiteren Schritt scheint es zudem möglich zu sein, eine 
nichtinvasive Beurteilung der Knorpeldicke und der Knorpeleigenschaften in vivo an 
regeneriertem Knorpel durchzuführen, um so die Qualität des Regeneratgewebes zu 
beurteilen.  Allerdings  wurde  die  Kalibrierung  des  Messsystems  bisher  nur  an 
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normalem und nicht degenerierten Knorpel durchgeführt. Es ist zu erwarten, dass die 
Situation bei degeneriertem Knorpel anders und komplexer ist und somit neue 
Analysen und Kalibrierungen erfordert, bevor das System beispielsweise als „hand- 
guided“ System bei humanen Operationen zum Einsatz kommt 
 
In der vorliegenden Arbeit konnte gezeigt werden, dass die standardisierte Untersuchung 
von  innovativen  bzw.  klinisch  etablierten  TE  Konstrukten  mit  dem  vorliegenden  in  vitro 
Modell über einen Zeitraum von bis zu 12 Wochen möglich ist, um mit den gewonnenen 
Ergebnissen  (molekularbiologisch  und  biomechanisch)  Vorhersagen  für  die  die  in  vivo 
„Performance“  von  Knorpelersatzmaterialien zu treffen.  Die Auswertung  der 
biomechanischen Untersuchungen der in vivo Proben erfolgte in Kooperation mit den 
Verbundpartnern des BMBF Projektes. Auf der Basis aller gewonnenen Erkenntnisse sollen 
nunmehr mit den Kooperationspartnern standardisierte Verfahren für die Prüfung von TE 
Konstrukten für den orthopädisch-unfallchirurgischen Einsatz entwickelt werden. 
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Suppl. Fig. 1: Quantitative analysis of proteoglycan content or release (DMB assay) or newly 
synthesized collagen 2 (ELISA) in cartilage-implant constructs (cell-free or cell-loaded 
implants). Proteoglycans (DMB assay) and newly synthesized collagen 2 (ELISA) were quantified in 
fresh and cultured ‘host’ cartilage matrix (cartilage), in cells located on the cartilage surface (cartilage 
surface), and in the culture supernatant (supernatant), when using cell-free collagen implants (A for 
proteoglycan; C for collagen 2) or cell-loaded collagen implants (B for proteoglycan; D for collagen 2); 
values are expressed as means ± SEM; symbols indicate p ≤ 0.05 versus * 0 weeks; # 4 weeks; x 8 
weeks; § versus cell-free. 
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Suppl. Fig. 2: Experimental setup. NIRS-B was performed on the cartilage surface of the 
osteochondral cylinders in isotonic saline using a NIR-spectrometer, synchronized with a linear 





Suppl. Fig. 3: Exemplary depiction of the factors (loadings; n = 5; named 1 to 5) and factor 
weights (scores) of several principal components based on the factor analysis of one NIR 
spectra. The data matrix of the NIR spectra is fragmented into factors and scores (in this example 
with 5 factors and 40 spectra, i.e., a total of 200 scores) to develop Model 2s (smoothed) for NIRS-B 
thickness prediction based on needle indentation. 
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Suppl. Fig. 4: Determination of the cartilage thickness by the gold standard needle indentation. 
Force [N] – displacement [mm] curve used for the identification of the tidemark and the subsequent 






Suppl. Fig. 5: NIRS absorbance spectrum for the same location in the intervals 1 (minimal 
indentation),  2  (maximal  indentation),  and  3  (relaxation).  The  complete  NIRS  absorbance 
spectrum displays the characteristic wavelength pattern of cartilage with maxima at λ = 950 nm, λ = 
1170 nm, and λ = 1450 nm (the insert shows a magnification of the spectra at 950 nm). 
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Suppl. Fig. 6: NIR spectra from cartilage samples of varying thickness (n = 6; three areas with 






Suppl. Fig. 7: Independent linear analysis for repeated measures of the NIRS performance 
(model 4r; n = 120). (A) Confidence intervals close to the prediction accuracy of NIRS-B (approx. 0.17 
mm); (B) highly significant, positive correlation between needle indentation and NIRS-B; (A-C) no 
significant indications for an offset of the values for the 2 methods from zero (B), for a significant inter- 
observer variability (B), or a deviation from a normal distribution (C). 
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Suppl. Fig. 8: Correlations between the values obtained by NIRS and histology. Visual depiction 
of the correlations between the values obtained by NIRS and histology for the different prediction 
models (including rho, p, and n for each correlation; compare with Table 4). 
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